header logo image


Page 444«..1020..443444445446..450460..»

Just how to live much longer: The foods shown to avoid heart disease and increase longevity – Entertainment Overdose

August 19th, 2020 2:53 pm

Although it is obvious tht food is vitl to onesn>survivl, mny people re unwren>how single compounds found in foods could impct disesen>nd mortlity.n>Leding helth experts nd reserchers recommend diet which is rich in polyphenols to help boost longevity nd reducen>then>risk of diseses.n>n>

In study published in Alph Glileo, diet high in polyphenols nd its ssocition with longevity ws investigted.

The study noted: It is the first time tht scientific study ssocites high polyphenols intke with 30 percent reduction in mortlity in older dults.n>n>

The reserch, published onJournl of Nutrition, is the first to evlute the totl dietry polyphenol intke by using nutritionl biomrker nd not only food frequency questionnire.n>n>

Reserchers found tht people who took in 650 mg per dy experienced 30 percent lower mortlity rte thn those who took in less thn 500 mg per dy.n>n>n>

n>

DONT MISS

Iron deficiency symptoms: The sign in your hair that could mean youre lacking iron[EXCLUSIVE]

Hair loss treatment: Using this oil could unclog hair follicles and increase hair growth[INSIGHT]

Pancreatic cancer symptoms: Having this colour pee could be a sign of the deadly disease[TIPS]

n>

Professor Cristin Andr&ecute;s Lcuev, hed of the Biomrkers nd Nutritionl ∓ Food Metbolomics Reserch Group of the UB nd coordintor of the study sid: The development nd use of nutritionl biomrkers enbles to mke more precise nd, prticulrly, more objective estimtion of intke s it is not only bsed on prticipnts memory when nswering questionnire.n>n>

Nutritionl biomrkers tke into ccount biovilbility nd individul differences.n>n>

This methodology mkes more relible nd ccurte evlution of the ssocition between food intke nd mortlity or disese risk.n>n>

Polyphenolsorpolyphenolrich diets provide significntprotection ginstthe development nd progression of mny chronic pthologicl conditions including cncer, dibetes, crdio-vsculr problems nd ging.n>n>

Polyphenol foods re known to help boost longevity nd fruits with high levels of polyphenols include blck chokeberries, blck elderberries, strwberries, red rspberries, blueberries, plums, ndn>blckcurrnts.n>n>

Coco powder, drk chocolte, coffee, te, nd flxseed re lso high in polyphenols.n>n>

When it comes to herbs nd sesonings withn>highn>levels of polyphenols, the Europen Journl of Clinicl Nutrition recommends cloves, dried peppermint, nd str nise.n>n>

The rest is here:
Just how to live much longer: The foods shown to avoid heart disease and increase longevity - Entertainment Overdose

Read More...

Stocks rally on new U.S. highs, dollar at two-year low – Reuters

August 19th, 2020 2:53 pm

NEW YORK (Reuters) - Global equities rose on Tuesday as strong corporate results and accelerating U.S. homebuilding lifted the S&P 500 past highs set before the coronavirus crushed world economies, in a stimulus-fueled rally that has also pushed the dollar to two-year lows.

FILE PHOTO: The Wall Street sign is pictured at the New York Stock exchange (NYSE) in the Manhattan borough of New York City, New York, U.S., March 9, 2020. REUTERS/Carlo Allegri/File Photo

Both the S&P 500 and Nasdaq Composite set records soon after the opening bell following strong sales growth as reported by major U.S. retailers including Walmart, Kohls and Home Depot.

The benchmark S&P 500 index topped an all-time peak reached in February just before the onset of COVID-19. The tech-heavy Nasdaq hit a record high for the second consecutive day in a session where declining stocks outnumbered rising shares.

(Graphic: S&P 500's bull-to-bear, bear-to-bull journey in 6 months here)

Its a reflection that the pandemic has limited longevity and the economic downtown will also have limited longevity, said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York, who acknowledged many investors are skeptical about a rally that confirms a bull market.

We feel in about a year or so most of the population will be immunized with a vaccine and the economy will begin to return to accelerated growth, Ghriskey said.

Historically low interest rates and very accommodative monetary and fiscal policy in the United States and abroad have aided the rally, said William Northey, senior investment director at U.S. Bank Wealth Management in Helena, Montana.

The policy responses have been incredibly forceful and provided a necessary bridge through this voluntary economic shutdown as we deal with these conditions created by the pandemic, Northey said.

The near-doubling of online sales in the second quarter helped Walmart Inc trounce Wall Street expectations for quarterly profit and same-store sales.

The S&P slumped to a pandemic low on March 23 and has surged about 55% since then, making the bear market that started in late February the benchmark indexs shortest in history.

The S&P 500 gained 0.23%, led by Amazon.com and the Nasdaq Composite added 0.73%. The Dow Jones Industrial Average fell 0.24%.

In Europe, the broad FTSEurofirst 300 index closed down 0.52% at 1,424.85. MSCIs world equity index of equity markets in 49 nations rose 1.65 points or 0.29%, to 573.53.

(Graphic: S&P 500 PE revisits dot-com highs here)

Gold rose more than 1% to climb back above the $2,000 level breached earlier this month, as the dollar fell against a basket of major currencies for a fifth consecutive trading day, under pressure from low yields and mostly bleak U.S. economic data.

The Feds intervention in financial markets to maintain liquidity in the midst of the coronavirus pandemic has weakened the dollar, pushed risk assets to all-time highs and reduced demand for safe-havens.

The dollar index fell 0.551%, with the euro up 0.53% to $1.1932. The Japanese yen strengthened 0.60% versus the greenback to 105.38 per dollar.

Spot gold prices rose 0.74% to $2,000.19 an ounce. U.S. gold futures settled up 0.7% at $2,013.10.

U.S. housing starts jumped 22.6% in July in the latest sign homebuilding is emerging as one of the few areas of strength in an economy suffering a record slowdown because of the pandemic.

U.S. Treasury yields slid as the market largely snubbed the strong housing data and looked for signs that a political stalemate in Washington over a round of aid was easing.

The benchmark 10-year Treasury note fell 1.8 basis points to yield 0.6655%.

Oil prices settled modestly higher in choppy trade. Brent crude futures rose 9 cents to settle at $45.46 a barrel. U.S. crude futures settled unchanged at $42.89 a barrel.

Reporting by Herbert Lash, additional reporting by Stephen Culp in New York and Medha Singh in Bengaluru.; Editing by Nick Zieminski and Andrea Ricci

See more here:
Stocks rally on new U.S. highs, dollar at two-year low - Reuters

Read More...

Coronavirus may have come from bats; could they also hold clues to treatments? – Health24

August 19th, 2020 2:53 pm

Bats have been blamed as a possible source of the new coronavirus pandemic ravaging the globe. But they might also point to possible ways out of it.

Scientists say the winged mammals' immune systems may offer clues on how to fight the new coronavirus and other dangerous viruses in humans.

"Humans have two possible strategies if we want to prevent inflammation, live longer and avoid the deadly effects of diseases like Covid-19," explained study lead author Vera Gorbunova, a professor of biology at the University of Rochester in New York. "One would be to not be exposed to any viruses, but that's not practical. The second would be to regulate our immune system more like a bat."

Resistance and longevity

Many deadly viruses that affect people are believed to have originated in bats, including rabies, Ebola and SARS-CoV-2, the strain that causes Covid-19. But bats have evolved a secret weapon: They're better able to tolerate viruses than humans and other mammals.

"We've been interested in longevity and disease resistance in bats for a while, but we didn't have the time to sit and think about it," Gorbunova said in a university news release.

"Being in quarantine gave us time to discuss this, and we realised there may be a very strong connection between bats' resistance to infectious diseases and their longevity. We also realised that bats can provide clues to human therapies used to fight diseases," she explained.

Typically, a species' lifespan is associated with its body size. The smaller a species, the shorter its lifespan. But many bat species have lifespans of 30 to 40 years, which is impressive for their size, the authors noted in a review article published recently in Cell Metabolism.

Bats' longevity and tolerance to viruses may be due to their ability to control inflammation, which is involved in both ageing and disease. Viruses, including Covid-19, can trigger inflammation.

Our bodies overreact

With Covid-19, this inflammatory response goes "haywire", Gorbunova said. In fact, in many cases it is the inflammatory response that kills the patient, more so than the virus itself.

"The human immune system works like that: Once we get infected, our body sounds an alarm and we develop a fever and inflammation. The goal is to kill the virus and fight infection, but it can also be a detrimental response as our bodies overreact to the threat," Gorbunova said.

In contrast, bats' immune systems control viruses without mounting a strong inflammatory response.

There are several possible reasons why bats evolved to fight viruses and live long lives. Flight may be one of them, the researchers noted.

Constant exposure to viruses

Bats are the only mammals that can fly, which required them to adapt to rapid increases in body temperature, sudden surges in metabolism and molecular damage. These adaptations may also assist in disease resistance, the study authors suggested.

Another factor is that many species of bats live in large, dense colonies, and hang close together on cave ceilings or in trees. Those conditions are ideal for transmitting viruses and other pathogens.

According to Andrei Seluanov, a biology professor at the University of Rochester, "Bats are constantly exposed to viruses. They are always flying out and bringing back something new to the cave or nest, and they transfer the virus because they live in such close proximity to each other."

This means that bats' immune systems are continuously adapting to deal with new viruses. Studying bats' immune systems could lead to new ways to fight aging and diseases in humans, the researchers said.

Image credit: Igam Ogam, Unsplash

See the rest here:
Coronavirus may have come from bats; could they also hold clues to treatments? - Health24

Read More...

The coronavirus is mutating and that could be a very good thing, says infectious disease expert | TheHill – The Hill

August 19th, 2020 2:53 pm

Following the emergence of COVID-19 out of Wuhan, China, late last year, scientists as early as February discovered a slight mutation of the coronavirus that has now become a more predominant variant in Europe and North America andwas recently found in parts of Asia.

While the World Health Organization has said there is no evidence the D614G mutation has led to more harmful cases of COVID-19, theres been some research indicating it may be much more infectious than the strain that first appeared in China.

America is changing FASTER THAN EVER. Add Changing America to yourFacebookandTwitterfeeds to stay engaged on the latest news and smartest insights.

A prominent infectious disease expert says a more infectious strain may actually be a good thing.

Maybe thats a good thing to have a virus that is more infectious but less deadly, Paul Tambyah, senior consultant at the National University of Singapore and president-elect of the International Society of Infectious Diseases, told Reuters in an interview.

Tambyah told the news outlet theres evidence the D614G mutation is less lethal as the increase in the strain in some parts of the world has coincided with a drop in death rates. He noted that most viruses tend to become less virulent as they mutate.

It is in the virus interest to infect more people but not to kill them because a virus depends on the host for food and for shelter, Tambyah told Reuters.

The strain was found recently in a Malaysian cluster of 45 cases that stemmed from someone who returned from India and breached a 14-day home quarantine, prompting authorities there to urge people to take greater precautions.

Malaysias Director-General of health Noor Hisham Abdullah on Sunday made the claim the D614G strain detected in the country was 10 times more infectious and may mean existing studies on vaccines may be incomplete or ineffective against the mutation.

Recent research, however, suggests the mutation is unlikely to have a majoreffect on the efficacy of vaccines currently being developed.

Public health experts who spoke with Reuters agreed.

(The) variants are almost identical and did not change areas that our immune system typically [recognize], so there shouldnt be any difference for vaccines being developed, Sebastian Maurer-Stroh of Singapores agency for science, technology and research told Reuters.

Continue reading here:
The coronavirus is mutating and that could be a very good thing, says infectious disease expert | TheHill - The Hill

Read More...

The mathematics of evolution – Pursuit

August 19th, 2020 2:53 pm

Every so often you think about a moment, and this sounds quite cliched, but its a moment that changed your life, but you didnt realise that it did. For me one of those moments was in year 10. Prior to that year, I was a bit cheeky at school. I was always getting into trouble and I wasnt that interested. And I think it was because I was bored, really.

I had the option to move up into the advanced maths class, but my teacher at the time said all sorts of ridiculous rabble, like people like me dont do maths, so I would struggle if I moved up. Because I am very head strong, I essentially told her to go get stuffed and moved up anyway. And because Im very competitive, I made it my goal to beat everyone in the class and I did that too.

I went to Oxford University and started investigating the evolution of sleep. Sleep as a behaviour, when you think about it from an evolutionary standpoint, makes very little sense. Why would such a vulnerable state evolve?

I submitted a paper, focusing on sleep, and one of the reviewers made a very good point; how do we distinguish sleep from rest? We need to talk about information collection if were to make that distinction. That then led me to thinking about how and when organisms are collecting information about their environment and when theyre not.

Have you heard of the grandmother hypothesis? I went on to look at the evolution of post-menopausal longevity. The grandmother hypothesis posits that post-menopausal grandmothers may increase the reproductive success in their children, and so indirectly their own fitness.

Read more

But significant post-menopausal representation (as opposed to viability) exist only in us humans and the toothed whales. I used a lot of game theory to show that in fact there are some very good reasons why you would expect it to be rare. Now, Im asking other questions, because while I really quite like the grandmother hypothesis I think its very elegant its also very hard to test.

So, for example, if grandmothering is so great, at what point do the benefits of it stop, in terms of increasing life span.

I moved from Oxford to Melbourne to be closer to family. Even just being in the same time zone as my family made a really big difference. Im on a McKenzie Fellowship which gives you an uncommon amount of freedom, for a young academic.

Mathematics can tell us a lot about the world and behaviours. There are famous studies from the 90s investigating the motivations of behaviour around risk. Say you give a bird two options it may be water with different amounts of sugar in it or it may be food. On average, the reward is the same, but the variances are different. If I starve the bird, will the bird go for the more risky option? If I make sure the bird has full energy reserves, will they be more conservative?

We need to reassess the classic studies of behaviour, because they mostly assume that the experimentalists and the experimental subject had the same frame of reference. But I would argue that in most cases, thats not true. I was able to show using some very simple mathematics that we need to be really cautious about the conclusions we draw from those experiments. You can show that, in a finite period of time, they will never agree that the expected rewards are the same.

My work now is looking at traditional Indigenous marriage rules. These are rules for who can marry whom; Im thinking about the mathematics of these rules and the evolutionary consequences of them. One reason Im interested is for very personal reasons, because it is my culture. And I strongly believe we must be keepers of our own knowledge.

Read more

But the other reason is that at the turn of the last century a lot of people were studying these rules, but they were sort of swept aside as cultural artifacts, not having much utility or reasoning behind them.

Indigenous marriage rules are actually quite clever systems to prevent a lot of diseases from spreading. I can show, just with pen-and-paper mathematics, that by following the marriage rules, the entire population of the Gamilaraay Nation (where Im from) which extends from New South Wales to southern Queensland would have to reduce to 24 individuals for people to be as closely related as first cousins when marrying. Thats 24 people, over a landmass that is the size of France.

In the 1850s, the upper crust in England were doing this on purpose. Charles Darwin married his first cousin.

I would argue that this is science. Although Indigenous marriage rules may not be couched in modern scientific terms, to understand these things is to very closely observe, using intense longitudinal studies. This is science.

There are only around five Indigenous mathematicians in the country, and most of them have left academia because of racism. I decided to apply to the ABCs Top 5 Media Residency Program because Im hoping that being a little more visible might encourage other black people to dive into maths.

There are very few of us out here saying Im a black mathematician or Im a black scientist. I think, maybe, thats because we need reminding that not only are we capable, but weve always been capable.

- As told to Dr Daryl Holland

See more here:
The mathematics of evolution - Pursuit

Read More...

City of Corbin to hire lawyer in annexation fight with London – ABC 36 News – WTVQ

August 18th, 2020 9:01 am

CORBIN, Ky. (WTVQ) The Corbin City Commission voted unanimously Monday to hire an attorney in an annexation fight with the City of London, according to a report in The News Journal.

The report says the commission approved a motion to hire lawyer Patrick Hughes.

The area in question is along the West Cumberland Gap Parkway. It is not within the Corbin city limits, but the city installed the water and sewer lines that service that area, according to the report.

The City of London would be required to get permission from the City of Corbin to annex over its existing infrastructure, according to The News Journal.

Corbin cant annex the area because state law only permits a city to annex in a county where it is chartered, according to the report.

Attempts by state lawmakers to amend the existing law that would allow Corbin to annex the area have been unsuccessful, according to The News Journal.

Tom Kenny joined ABC 36 News in June of 2001 as a General Assignment Reporter. A native of Peoria, Illinois, he graduated cum laude with a Bachelor of Arts in Mass Communications from Western Illinois University. He currently anchors ABC 36 News at 5pm, 6pm and 11pm.Tom has more than three decades of experience in broadcast journalism. He is the only broadcast journalist in Lexington television history to be honored with a national Edward R. Murrow Award. Tom was recognized for reporting on a story that gave a rare glimpse inside the secretive world of the Federal Witness Protection Program. He has won an Emmy Award for anchoring and another for investigative reporting, exposing the deceit and potential danger of online diploma mills.Tom has ten other Emmy nominations to his credit for investigative and feature reporting. He has won Associated Press Awards for reporting and anchoring. He has won two Addy Awards for excellence in promotional writing. Tom was the first broadcast journalist in Lexington TV history to be awarded the Silver Circle Award by the National Academy of Television Arts and Sciences. It is one of the highest honors given by NATAS. It recognizes television professionals who have performed distinguished service within the television industry for 25-years or more. Tom was honored for more than his longevity, he was recognized for making an enduring contribution to the vitality of the television industry and for setting high standards of achievement. He was also recognized for giving back to the community as a mentor, educator and volunteer. Tom also has network broadcast experience in radio and television having worked as a sports reporter for ESPN, Sportschannel, NBC Sports and the Breeders Cup. He was also the studio host and halftime producer for CBS Radio Sports College Football Game of the Week and covered the NFL for One-On-One Radio Sports.Prior to joining WTVQ-TV, Tom was Vice-President of the Houston Astros Minor League baseball team in Lexington. He was part of the original management team that brought professional baseball back to the Bluegrass after a nearly 50-year absence.Tom has lived in Lexington since 1984. In that time, he has been heavily involved with dozens of charity and civic groups, with a special emphasis on helping Veterans. He can be reached at tkenny@wtvq.com. You can also follow Tom on Facebook http://www.facebook.com/TomKennyABC and Twitter @TomKennyNews. Just click on the links at the top of the page.

Continued here:
City of Corbin to hire lawyer in annexation fight with London - ABC 36 News - WTVQ

Read More...

RUSSELL GLOOR: Ask Rusty – About the virtues of claiming benefits early – Houston Chronicle

August 18th, 2020 9:01 am

Dear Rusty: It seems like we are always encouraged to wait until our full retirement age or age 70 to claim our Social Security. For me, benefits at age 62 were a good jump start to my retirement. How about listing the many benefits to early (age 62) retirement? And at what age does it become a liability, if ever? Signed: Happily Retired at age 78

Dear Happily Retired:

Youre correct that most financial advisors and Social Security advisors, including me, frequently encourage people to delay claiming Social Security until at least their full retirement age (FRA). And thats because far too many claim their benefits as soon as they are available at age 62 because its there, without evaluating whether thats a smart move for them personally. There are many reasons why its best to wait, but there are also some very good reasons for claiming benefits at age 62. Lets explore those.

Claiming at age 62 is exactly the right move if you are in poor health and dont expect to live a long life. Benefits taken age 62 are 25 percent less for those with a full retirement age (FRA) of 66, and 30 percent less if your FRA is 67. But those reductions become insignificant if you dont expect to live a long, healthy life from that point forward. If you wait until your FRA, it takes about 12 years to collect the same amount in total benefits as if you had claimed at age 62.

Even if you are in decent health now, if your family history and your lifestyle suggest less than average longevity, claiming before your FRA, as early as 62, may be a prudent choice. By lifestyle I mean, for example, whether you exercise regularly, smoke or drink excessively or drive without a seatbelt. There are several life expectancy calculators available which can assist with predicting your life expectancy by evaluating your family history and lifestyle, including those available at this website: https://socialsecurityreport.org/tools/life-expectancy-calculator. Just remember that no one can accurately forecast how long they will live but making an informed decision on when to claim should consider your estimated longevity, among other things.

If collecting your Social Security benefits early is needed to help pay for lifes necessities, such as food, housing, and out-of-pocket medical costs, then claiming as early as age 62, or any other time before your FRA, could be exactly the right choice. In other words, the need for the money now is a driving force in deciding when to claim.

Which brings me to your point that claiming at age 62 was a jump start to your retirement, allowing you to begin enjoying your golden years much earlier than you might have otherwise been able to. Theres a lot to be said for taking benefits early to fulfill your bucket list while youre still young enough to enjoy it. And, from your signature, it looks like youve been putting that extra Social Security money to good use for many years now. Good for you! Now, at age 78, youve reached your breakeven point where, if you had waited until your FRA to claim, your cumulative lifetime benefits would hereafter be more than they will be because you claimed at 62. That may not, however, offset the many years of happy retirement youve been able to enjoy because you took your benefits early.

In the end, deciding when to claim Social Security should be done after carefully evaluating your personal situation. Anyone who claims benefits before their full retirement age must beware of Social Securitys earnings test which limits how much you can earn before your benefits are affected. But those who can afford to wait and who expect to live to a ripe old age would do well to consider delaying until their full retirement age, or even beyond, to claim their Social Security benefits. If their life expectancy is at least average theyll collect much more in cumulative lifetime benefits by doing so.

Russell Gloor is a certified Social Security advisor with the Association of Mature American Citizens.

Read more:
RUSSELL GLOOR: Ask Rusty - About the virtues of claiming benefits early - Houston Chronicle

Read More...

Increase in wastewater rates to get first reading – York News-Times

August 18th, 2020 9:01 am

YORK A proposed 9 percent increase in wastewater rates is being proposed for the City of York and the first reading of an ordinance that would enact that increase will be held this coming Thursday.

Earlier, it was proposed that a higher rate increase would be needed, but then later determined that a smaller increase would be sufficient.

The increase is attributed to the citys large project of building a new wastewater treatment plant and installing all the infrastructure that goes a long with it.

The good news is that no rate increases are being proposed this year for water or for the landfill.

Also on Thursday night, during the city councils regular meeting, the following will be discussed:

A second reading of an ordinance addressing longevity pay for employees will be held. Getting rid of or altering the citys longevity pay program has come and gone over the past few years, only to come back again.

The council will consider the sale of a small piece of land to Matt and Lynn Leif, for $1,500.

The council will also hold a discussion about the budget for the new 2020-21 fiscal year. The council, administration and department heads have been discussing budget issues for quite some time now. Approval is nearing. As the budget looks at this time, there will likely not be any increase of the tax levy and reserves are projected to be more than $2 million when the fiscal year ends.

The public is always encouraged to attend the meeting, which will begin at 7 p.m., in the council chambers, on Thursday, Aug. 20.

Here is the original post:
Increase in wastewater rates to get first reading - York News-Times

Read More...

To Live Longer, Healthier, Avoid Saturated Fat in Meat and Dairy – The Beet

August 18th, 2020 9:01 am

The observation that diet and health are related can be traced back at least to Maimonides a 1,000 years ago and Hippocrates over 2,000 years ago. With advances in public health measures and medical care, the average lifespan has been dramatically extended. Unfortunately, many of the extra years are burdened with chronic diseases, like heart disease and cancer.

More than ever, trying to determine what diet is most related to health is of importance to living a long life without disease. Nutrition science can be difficult, complex, and conflicting at times. What can you do when headlines appear that are in direct conflict with one another? Is the media biased, or even bought?

In the last few months, this situation has exploded, and it pertains to the role of whole food plant diets and heart disease. Research on the contribution of foods rich in saturated fats like cheese, butter, meats, eggs, and pastries to heart disease has been ongoing since the 1950s. In order to evaluate the most current and quality data, a systematic review and meta-analysis of the relationship between saturated fat and heart disease were published by the Cochrane Database of Systematic Reviews (CDSR)in May. The CDSR is widely regarded as the leading and most respected of sources for evaluating topics in health care.

The authors analyzed 15 controlled trials involving over 59,000 subjects and concluded that The findings of this updated review suggest that reducing saturated fat intake for at least two years causes a potentially important reduction in combined cardiovascular events (21%). Replacing the energy from saturated fat with polyunsaturated fat or carbohydrate appears to be useful strategies. It would seem clear that reducing or eliminating meats, cheeses, egg yolks, lard, butter, ghee and baked goods would favor better odds of avoiding heart disease. Of note, major media channels did not report on this research and it was buried in the National Library of Medicine.

The clarity on nutrition advice provided by the esteemed CDSR lasted all of 3-4 weeks as a State of the Art Review by 12 authors on the topic of saturated fat and health was published in a major cardiology journal on June 16, 2020. They did not conduct original research but analyzed previously published studies. The 12 authors concluded that Whole-fat dairy, unprocessed meat, eggs and dark chocolate are SFA-rich foods with a complex matrix that are not associated with increased risk of CVD. The totality of available evidence does not support further limiting the intake of such foods. Unlike the esteemed CDSR paper, this review created 100s of headlines worldwide.

How can we reconcile such conflicting conclusions? It is challenging and leaves many confused, feeling that they can eat whatever they want while nutrition scientists duke it out. One major concern not mentioned in the media regarding the 2nd paper promoting saturated fat was that 9 of the 12 authors disclosed research funding by dairy or beef foundations. Lets repeat that: 75% of the authors promoting saturated fat were funded by industry organizations that promote foods rich in saturated fat!

In a second challenge to the findings of the CDSR, 10 authors published a hypothesis that those suffering from a relatively rare genetic disorder causing high cholesterol, familial hyperlipidemia, would benefit more from a low-carbohydrate diet than a low-fat diet. The authors did not conduct original research. Guess what? Five of the 10 authors revealed financial ties that they benefit from relating to low-carb diets. The other 5 are well known low-carb advocates routinely advocating for dietary approaches in conflict with major medical societies and research findings. Would you be surprised that this paper also got worldwide headlines indicating that a new paradigm had been identified?

Are there any ways to approach nutrition research with a system you can digest when new data and conflicting reports appear? I rely on two leading research scientists who have proposed such an approach:One is Valter Longo, Ph.D., author of The Longevity Diet, creator of the plant-based Fasting Mimicking Diet, and internationally known leading academic researcher.

Dr. Longo describes the Five Pillars of Longevity as a format to evaluated nutrition research. These 5 pillars are:1) biochemical research, 2) randomized trials, 3) epidemiology, 4) study of centenarians, and finally, 5) analysis of complex systems (like the environmental impact of diet). For example, Dr. Longo considers the popular keto diet to bea half a pillar at most as it lacks many of the components of this analytical system. In contrast, Dr. Longo teaches a plant-based diet in his book as it encompasses all 5 pillars.

The other leading scientist is Nobel Prize Laureate Michael Brown, MD who was awarded this high honor in 1985 for his research on the LDL cholesterol.Dr. Brown delivered a lecture titled A Century of Cholesterol and Coronaries and described a method of evaluating the scientific literature on the relationship between cholesterol and heart disease. He called the method the Four Lines of Evidence. These 4 lines were remarkably similar to the Pillars described by Dr. Longo. Together they provide a framework to consider new information in a meaningful and big picture way.

What can be concluded regarding saturated fat and heart disease? Should you add butter to your coffee tomorrow? One study was published by an esteemed organization (CDSR). The other two were written by authors with major financial biases, including investments in companies dedicated to promoting diets high in saturated fats.

Using the 5 Pillars or the 4 Lines of Evidence, there exists biochemistry, randomized trials, epidemiology, and Centenarian data that indicate that diets lower in saturated fats (reduced or absent meats, cheeses, butter, pastries, lard, ghee) promote health and reduce the risk of heart disease. No single new study can up-end 70 years of research, even if a new study can get inordinate and inappropriate praise in the media. While nutrition science can be challenging, using the methods here as a guidepost to the research you believe will help you make healthy decisions about your diet. One simple rule: Always favor plant-based selections. Do not believe all media headlines. They can be bought or, at a minimum, influenced, by a flow of dollars that generates clickbait headlines.

More here:
To Live Longer, Healthier, Avoid Saturated Fat in Meat and Dairy - The Beet

Read More...

DC Universe original TV shows will move to HBO Max – Business Insider Australia

August 18th, 2020 9:01 am

Speculation intensified about the future of the fan-centric DC Universe streaming service after DC was hit with massive layoffs on Monday as part of a larger restructuring for its parent company, WarnerMedia. The majority of the DCU staff was laid off, according to The Hollywood Reporter.

In an interview with THR addressing the layoffs on Friday, DC publisher and creative chief Jim Lee said that the original content that is on DCU is migrating to HBO Max, confirming that DCUs original TV shows will move to WarnerMedias new flagship streaming platform that launched in May.

Truthfully, thats the best platform for that content, Lee told THR. The amount of content you get, not just DC, but generally from WarnerMedia, is huge and its the best value proposition if Im allowed to use that marketing term. We feel that is the place for that.

DCUs Doom Patrol and Harley Quinn are already streaming on Max. Another DC Universe original, Stargirl, was renewed last month for a second season exclusively on The CW network.

But the writing has been on the wall for months regarding DCUs originals. Last year, DCU abruptly cancelled its original series Swamp Thing after one season, shocking crewmembers. In May, ahead of Maxs launch, Business Insider reported that WarnerMedia wasnt prioritising DCU. People close to the service questioned its longevity.

Everything is about HBO Max now, said a former employee of Warner Bros. Digital Labs, a product unit that works with the companys streaming services.

And in an interview in May, Maxs former content chief Kevin Reilly who was fired this month as part of the WarnerMedia shakeup told Business Insider that there had been extensive discussions around DCU because DC is such a valuable entity to us and the depth of fandom is so important.

DCU shows wont be the only original DC content on Max. The streamer is developing its own DC originals, including a Green Lantern spinoff of next years The Batman movie about the Gotham City police. Reilly told Business Insider that fans should expect the highest level of cinematic production values on the shows.

While DCUs original content will be leaving the service, Lee told THR that its definitely not going away. The service also serves as a community hub for fans and offers a library of digital comics.

In regards to the community and experience that DCU created, and all the backlist content, something like 20,000 to 25,000 different titles, and the way it connected with fans 24-7, there is always going to be a need for that, Lee said. So were excited to transform it and well have more news on what that will look like.

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.

Follow this link:
DC Universe original TV shows will move to HBO Max - Business Insider Australia

Read More...

Viewpoint: Is there a scientific basis to ban gene drive technology that can rid us of virus-carrying rodents and mosquitoes? – Genetic Literacy…

August 18th, 2020 9:00 am

Gene drives may be invaluable tools to control the spread of parasites, invasive species, and disease carriers. But the technology has faced strong opposition from activist groups and some mainstream scientists based on environmental and food safety. Are these concerns valid?

On June 30, some 80 environmental organizations, led by Greenpeace EU, Friends of the Earth Europe and Save Our Seeds, signed an open letter to the European Commission asking for support for a global moratorium on gene drive technology. The advocacy groups claimed that the release of gene drives poses serious and novel threats to biodiversity and the environment at an unprecedented scale and depth.

Citing a report by the European Network of Scientists for Social and Environmental Responsibility (ENSSER), the coalition wrote:

in light of the unpredictabilities, the lack of knowledge and the potentially severe negative impacts on biodiversity and ecosystems, any releases (including experimental) of Gene Drive Organisms into the environment be placed on hold to allow proper investigation until there is sufficient knowledge and understanding.

The environmental claims were unsupported by any documents other than the report by ENSSER, a controversial group of anti-biotechnology activist scientists co-founded by Gilles-ricSralini, best known for his retracted and discredited 2012 paper linking GMOs to cancer in rats.

The European parliament has already supported such a moratorium, an act that echoes EUs precautionary approach to genetic engineering, transgenic organisms and gene editing. The EU stated reasons include:

Recent advances in genetics and synthetic biology, particularly the development of CRISPR gene editing tools, have given scientists a powerful way to address problems created by pests, from mosquitoes to rodents, that vector disease to humans. In classical genetics, genes that offer adaptation benefits to individuals tend to increase their occurrence in the population while genes that reduce fitness tend to disappear.

Gene drives are genetic sequences designed to spread strongly and become present in every individual of a targeted species after a few generations. The genes may offer benefits, be neutral for adaptation purposes, or hinder their carriers survival and reproduction potential.Generation after generation, it would relentlessly copy and paste the gene it carried, until the gene and the desired trait was present in every descendant.Because the spread of a trait happens over generations, a gene drive works best in species that reproduce quickly, like insects and rodents

Gene drives are the first genetic constructs that can theoretically affect a population in its entirety, and quickly. It could even lead to the extinction of entire species, as gene drive critics allege. Species distinction has been part of life and evolution for all of Earths history. Although the data are fuzzy and contested, the UN Convention on Biological Diversity concluded that 150-200 plant, insect bird, and mammal species go extinct every day.

The likelihood that a gene drive will destroy a species in part or in whole, such as the infectedAedes aegyptimosquito species that carries the Zika, dengue and chingunya viruses and offers no known environmental benefits, is nonetheless daunting to some. On the one hand, gene drives could be used to eradicate disease such as malaria and yellow fever by controlling the mosquitoes that transmit them. On the other hand, critics fear that the technology will open a Pandoras Box; removing a species that theoretically could resultin what is popularly and controversially known as the butterfly effect.

As imagined by MIT meteorologist Edward Lorenz 60 years ago, a tiny environmental changesay an extinction of a pestcould dramatically and unpredictably result in unpredictable or even catastrophic consequences (Lorenz imagined abutterflyflapping its wings and causing a typhoon).

In the last few years, various groups have called for a global moratorium on gene drives. Such attempts were resisted at the 2016 and 2018 United Nations Conventions on Biological Diversity, mainly due to the strong opposition of many scientists and sub-Saharan African nations hardest hit by disease-vectored pests. Nevertheless, gene drive opponents have gained traction and gene drive research and applications face significant regulatory obstacles across the world (see Genetic Literacys Global Gene Editing Regulation tracker for a country-by-country analysis).

What does the scientific evidence say about gene drives and their environmental consequences?

There are over 3,000 mosquito species, likely a fraction of the number of species that have existed over some 100 million years. A handful of these (Aedes, Anopheles, and Culex species) are disease vectors and transmit infections such as malaria, yellow fever, the West Nile virus, Zika, and dengue fever. Mosquito-borne disease account for more than 17% of all infectious diseases and cause more than 700,000 deaths every year. These mosquitoes are mostly invasive in their ecological distributions.

Ultimately, there seem to be few things that mosquitoes do that other organisms cant do just as wellexcept perhaps for one, reported Nature magazine ina 2010 article A World Without Mosquitoes.

They are lethally efficient at sucking blood from one individual and mainlining it into another, providing an ideal route for the spread of pathogenic microbes. The Nature article concluded that wiping out mosquitoes wouldnt be a badthing. In fact, they could restore rather than harm the ecosystem. The same can be inferred for most parasitic insects, which are specialized to a particular host and normally dont have an extended ecological interactions network.

Invasive species also cause significant environmental hazards. Cane toads, having no natural predators, are slowly taking over the Australian continent from the northeast. Invasive fish from the red sea are wrecking havoc in the Mediterranean marine ecosystems. Rodents have spread in every conceivable corner of the earth, displacing vulnerable local fauna.

Gene drives might be one of the only ways to contain their spread, protecting biodiversity. They can be a powerful conservation tool that targets only the organism of interest, unlike contemporary pest management techniques such as the use of insecticides that attack all insects indiscriminately, or introduction of natural predators from other ecosystems (that by default disturb the food chains and interactions network).

It is possible for a DNA sequence to jump from one species to the other through a process called horizontal gene transfer. This theoretically could happen between insects, which appears to lend support to the argument that there is at least a small chance for a gene drive to move from species to species with unforeseen consequences.

The truth is that gene drives can be designed to target a very specific area of the genome, unique for a species. The modern gene drives use the precise CRISPR base editing technologies to spread to the population. In the off chance that the DNA encoding the gene drive will enter the reproductive cells of an individual from the other species, the editing system will have no template to act upon and the gene will be lost. One may argue that CRISPR has a chance for off-target activity, but a gene drive needs maximum efficiency to act as a gene drive. If the CRISPR doesnt work at 100%, the DNA sequence will be subject to the typical laws of inheritance and will disappear from the genetic pool

The ability to introduce genetic information to a wild population, which will spread to every individual, is unfortunately a dual use technology. The technology can theoretically be exploited to make biological weapons, though theres no indication that such a weapon is or has been developed. As gene drives can work well across many generations and require a large amount of offspring, they are unable to directly harm humans, crops, and farm animals. But a gene drive could be used to enhance the fitness of a crop-eating insect or a disease-carrying rodent.

The solution to this potential hazard is more research (and definitely not a research moratorium). Anyone with the means (which are considerable, so no lone bioterrorists or rogue scientists) and intent to cause harm can already research into such applications and will ignore aUN-imposed technology ban. The research community needs to develop the means to detect and monitor any malicious gene drive release and counter any offensive use.

The question on who and how should approve gene drive projects isnt easy to answer. A gene drive isnt contained by country borders, and the outdated GMO regulation framework existing in most countries is scientifically outdated and practically inadequate to handle such applications.

Moreover, the technology cannot be monopolized by a few countries or private companies. Each project is different. The approval should be a result of consensus among numerous stakeholders. There should also be a defined way to monitor how the gene drive spreads and how to handle liability claims if there are negative effects.

With populism growing and fewer people willing to trust the judgment of regulators and scientists, the rhetoric around complex innovations has become increasingly polarized, with both sides stuck fighting a high-stakes battle for public opinion. The issue is complex, and any decisions cannot be left to scientists, state organizations, and companies alone. But it also cannot be left solely in the hands of environmental organizations with little or no understanding of the science and with an ideological agenda that doesnt necessarily serve the public.

Environmental groups have often resorted to hyperbole as the debate over gene drives has unfolded. At the UN Convention on Biological Diversity in Sharm el Sheikh, Egypt, in 2018, a coalition of activists compared gene drives to the atomic bomb and accused researchers of using malaria as a Trojan horse to cover up the development of agricultural gene drives for corporate profit.A handful of small NGOs in the US, collectively known as SynBioWatch, have taken to describing gene-drive researchers as a cabal. The Canadian anti-biotechnology organization ETC Group claims aggressively spreads misinformation on social media, including claims that gene-drive honeybees could supposedly be controlled with a beam of light.

Meanwhile, Florida Keys is experiencing the largest dengue fever outbreak in a decade, with close to 40 cases already documented. The outbreak has led the Florida Keys Mosquito Control District to enter a partnership with UK-based, US-owned Oxitec that could lead to the Keys becoming the first U.S. trial site for genetically modified Aedes aegypti mosquitoes.

With a technology that can prevent hundreds of thousands of deaths per year, it is unethical to peremptorily ban it because it doesnt fit a few peoples worldview of what is natural. One may argue that governments and regulators should have no say whether one species should go extinct or not. But one can also question why activist groups in North America or Europe should be able to insert themselves in life and death decisions, preventing initiatives across the globe that could save millions of lives and protect our populations health and crops, and promote biological diversity.

Kostas Vavitsas, PhD, is a Senior Research Associate at the University of Athens, Greece. He is also a steering committee member of EUSynBioS. Follow him on Twitter@konvavitsas

Excerpt from:
Viewpoint: Is there a scientific basis to ban gene drive technology that can rid us of virus-carrying rodents and mosquitoes? - Genetic Literacy...

Read More...

Biotechnology Could Change the Cattle Industry. Will It Succeed? – Singularity Hub

August 18th, 2020 9:00 am

When Ralph Fisher, a Texas cattle rancher, set eyes on one of the worlds first cloned calves in August 1999, he didnt care what the scientists said: He knew it was his old Brahman bull, Chance, born again. About a year earlier, veterinarians at Texas A&M extracted DNA from one of Chances moles and used the sample to create a genetic double. Chance didnt live to meet his second self, but when the calf was born, Fisher christened him Second Chance, convinced he was the same animal.

Scientists cautioned Fisher that clones are more like twins than carbon copies: The two may act or even look different from one another. But as far as Fisher was concerned, Second Chance was Chance. Not only did they look identical from a certain distance, they behaved the same way as well. They ate with the same odd mannerisms; laid in the same spot in the yard. But in 2003, Second Chance attacked Fisher and tried to gore him with his horns. About 18 months later, the bull tossed Fisher into the air like an inconvenience and rammed him into the fence. Despite 80 stitches and a torn scrotum, Fisher resisted the idea that Second Chance was unlike his tame namesake, telling the radio program This American Life that I forgive him, you know?

In the two decades since Second Chance marked a genetic engineering milestone, cattle have secured a place on the front lines of biotechnology research. Today, scientists around the world are using cutting-edge technologies, from subcutaneous biosensors to specialized food supplements, in an effort to improve safety and efficiency within the $385 billion global cattle meat industry. Beyond boosting profits, their efforts are driven by an imminent climate crisis, in which cattle play a significant role, and growing concern for livestock welfare among consumers.

Gene editing stands out as the most revolutionary of these technologies. Although gene-edited cattle have yet to be granted approval for human consumption, researchers say tools like Crispr-Cas9 could let them improve on conventional breeding practices and create cows that are healthier, meatier, and less detrimental to the environment. Cows are also being given genes from the human immune system to create antibodies in the fight against Covid-19. (The genes of non-bovine livestock such as pigs and goats, meanwhile, have been hacked to grow transplantable human organs and produce cancer drugs in their milk.)

But some experts worry biotech cattle may never make it out of the barn. For one thing, theres the optics issue: Gene editing tends to grab headlines for its role in controversial research and biotech blunders. Crispr-Cas9 is often celebrated for its potential to alter the blueprint of life, but that enormous promise can become a liability in the hands of rogue and unscrupulous researchers, tempting regulatory agencies to toughen restrictions on the technologys use. And its unclear how eager the public will be to buy beef from gene-edited animals. So the question isnt just if the technology will work in developing supercharged cattle, but whether consumers and regulators will support it.

Cattle are catalysts for climate change. Livestock account for an estimated 14.5 percent of greenhouse gas emissions from human activities, of which cattle are responsible for about two thirds, according to the United Nations Food and Agriculture Organization (FAO). One simple way to address the issue is to eat less meat. But meat consumption is expected to increase along with global population and average income. A 2012 report by the FAO projected that meat production will increase by 76 percent by 2050, as beef consumption increases by 1.2 percent annually. And the United States is projected to set a record for beef production in 2021, according to the Department of Agriculture.

For Alison Van Eenennaam, an animal geneticist at the University of California, Davis, part of the answer is creating more efficient cattle that rely on fewer resources. According to Van Eenennaam, the number of dairy cows in the United States decreased from around 25 million in the 1940s to around 9 million in 2007, while milk production has increased by nearly 60 percent. Van Eenennaam credits this boost in productivity to conventional selective breeding.

You dont need to be a rocket scientist or even a mathematician to figure out that the environmental footprint or the greenhouse gases associated with a glass of milk today is about one-third of that associated with a glass of milk in the 1940s, she says. Anything you can do to accelerate the rate of conventional breeding is going to reduce the environmental footprint of a glass of milk or a pound of meat.

Modern gene-editing tools may fuel that acceleration. By making precise cuts to DNA, geneticists insert or remove naturally occurring genes associated with specific traits. Some experts insist that gene editing has the potential to spark a new food revolution.

Jon Oatley, a reproductive biologist at Washington State University, wants to use Crispr-Cas9 to fine tune the genetic code of rugged, disease-resistant, and heat-tolerant bulls that have been bred to thrive on the open range. By disabling a gene called NANOS2, he says he aims to eliminate the capacity for a bull to make his own sperm, turning the recipient into a surrogate for sperm-producing stem cells from more productive prized stock. These surrogate sires, equipped with sperm from prize bulls, would then be released into range herds that are often genetically isolated and difficult to access, and the premium genes would then be transmitted to their offspring.

Furthermore, surrogate sires would enable ranchers to introduce desired traits without having to wrangle their herd into one place for artificial insemination, says Oatley. He envisions the gene-edited bulls serving herds in tropical regions like Brazil, the worlds largest beef exporter and home to around 200 million of the approximately 1.5 billion head of cattle on Earth.

Brazils herds are dominated by Nelore, a hardy breed that lacks the carcass and meat quality of breeds like Angus but can withstand high heat and humidity. Put an Angus bull on a tropical pasture and hes probably going to last maybe a month before he succumbs to the environment, says Oatley, while a Nelore bull carrying Angus sperm would have no problem with the climate.

The goal, according to Oatley, is to introduce genes from beefier bulls into these less efficient herds, increasing their productivity and decreasing their overall impact on the environment. We have shrinking resources, he says, and need new, innovative strategies for making those limited resources last.

Oatley has demonstrated his technique in mice but faces challenges with livestock. For starters, disabling NANOS2 does not definitively prevent the surrogate bull from producing some of its own sperm. And while Oatley has shown he can transplant sperm-producing cells into surrogate livestock, researchers have not yet published evidence showing that the surrogates produce enough quality sperm to support natural fertilization. How many cells will you need to make this bull actually fertile? asks Ina Dobrinski, a reproductive biologist at the University of Calgary who helped pioneer germ cell transplantation in large animals.

But Oatleys greatest challenge may be one shared with others in the bioengineered cattle industry: overcoming regulatory restrictions and societal suspicion. Surrogate sires would be classified as gene-edited animals by the Food and Drug Administration, meaning theyd face a rigorous approval process before their offspring could be sold for human consumption. But Oatley maintains that if his method is successful, the sperm itself would not be gene-edited, nor would the resulting offspring. The only gene-edited specimens would be the surrogate sires, which act like vessels in which the elite sperm travel.

Even so, says Dobrinski, Thats a very detailed difference and Im not sure how that will work with regulatory and consumer acceptance.

In fact, American attitudes towards gene editing have been generally positive when the modification is in the interest of animal welfare. Many dairy farmers prefer hornless cowshorns can inflict damage when wielded by 1,500-pound animalsso they often burn them off in a painful process using corrosive chemicals and scalding irons. In a study published last year in the journal PLOS One, researchers found that most Americans are willing to consume food products from cows genetically modified to be hornless.

Still, experts say several high-profile gene-editing failures in livestock and humans in recent years may lead consumers to consider new biotechnologies to be dangerous and unwieldy.

In 2014, a Minnesota startup called Recombinetics, a company with which Van Eenennaams lab has collaborated, created a pair of cross-bred Holstein bulls using the gene-editing tool TALENs, a precursor to Crispr-Cas9, making cuts to the bovine DNA and altering the genes to prevent the bulls from growing horns. Holstein cattle, which almost always carry horned genes, are highly productive dairy cows, so using conventional breeding to introduce hornless genes from less productive breeds can compromise the Holsteins productivity. Gene editing offered a chance to introduce only the genes Recombinetics wanted. Their hope was to use this experiment to prove that milk from the bulls female progeny was nutritionally equivalent to milk from non-edited stock. Such results could inform future efforts to make Holsteins hornless but no less productive.

The experiment seemed to work. In 2015, Buri and Spotigy were born. Over the next few years, the breakthrough received widespread media coverage, and when Buris hornless descendant graced the cover of Wired magazine in April 2019, it did so as the ostensible face of the livestock industrys future.

But early last year, a bioinformatician at the FDA ran a test on Buris genome and discovered an unexpected sliver of genetic code that didnt belong. Traces of bacterial DNA called a plasmid, which Recombinetics used to edit the bulls genome, had stayed behind in the editing process, carrying genes linked to antibiotic resistance in bacteria. After the agency published its findings, the media reaction was swift and fierce: FDA finds a surprise in gene-edited cattle: antibiotic-resistant, non-bovine DNA, read one headline. Part cow, part bacterium? read another.

Recombinetics has since insisted that the leftover plasmid DNA was likely harmless and stressed that this sort of genetic slipup is not uncommon.

Is there any risk with the plasmid? I would say theres none, says Tad Sonstegard, president and CEO of Acceligen, a Recombinetics subsidiary. We eat plasmids all the time, and were filled with microorganisms in our body that have plasmids. In hindsight, Sonstegard says his teams only mistake was not properly screening for the plasmid to begin with.

While the presence of antibiotic-resistant plasmid genes in beef probably does not pose a direct threat to consumers, according to Jennifer Kuzma, a professor of science and technology policy and co-director of the Genetic Engineering and Society Center at North Carolina State University, it does raise the possible risk of introducing antibiotic-resistant genes into the microflora of peoples digestive systems. Although unlikely, organisms in the gut could integrate those genes into their own DNA and, as a result, proliferate antibiotic resistance, making it more difficult to fight off bacterial diseases.

The lesson that I think is learned there is that science is never 100 percent certain, and that when youre doing a risk assessment, having some humility in your technology product is important, because you never know what youre going to discover further down the road, she says. In the case of Recombinetics. I dont think there was any ill intent on the part of the researchers, but sometimes being very optimistic about your technology and enthusiastic about it causes you to have blinders on when it comes to risk assessment.

The FDA eventually clarified its results, insisting that the study was meant only to publicize the presence of the plasmid, not to suggest the bacterial DNA was necessarily dangerous. Nonetheless, the damage was done. As a result of the blunder,a plan was quashed forRecombinetics to raise an experimental herd in Brazil.

Backlash to the FDA study exposed a fundamental disagreement between the agency and livestock biotechnologists. Scientists like Van Eenennaam, who in 2017 received a $500,000 grant from the Department of Agriculture to study Buris progeny, disagree with the FDAs strict regulatory approach to gene-edited animals. Typical GMOs are transgenic, meaning they have genes from multiple different species, but modern gene-editing techniques allow scientists to stay roughly within the confines of conventional breeding, adding and removing traits that naturally occur within the species. That said, gene editing is not yet free from errors and sometimes intended changes result in unintended alterations, notes Heather Lombardi, division director of animal bioengineering and cellular therapies at the FDAs Center for Veterinary Medicine. For that reason, the FDA remains cautious.

Theres a lot out there that I think is still unknown in terms of unintended consequences associated with using genome-editing technology, says Lombardi. Were just trying to get an understanding of what the potential impact is, if any, on safety.

Bhanu Telugu, an animal scientist at the University of Maryland and president and chief science officer at the agriculture technology startup RenOVAte Biosciences, worries that biotech companies will migrate their experiments to countries with looser regulatory environments. Perhaps more pressingly, he says strict regulation requiring long and expensive approval processes may incentivize these companies to work only on traits that are most profitable, rather than those that may have the greatest benefit for livestock and society, such as animal well-being and the environment.

What company would be willing to spend $20 million on potentially alleviating heat stress at this point? he asks.

On a windy winter afternoon, Raluca Mateescu leaned against a fence post at the University of Floridas Beef Teaching Unit while a Brahman heifer sniffed inquisitively at the air and reached out its tongue in search of unseen food. Since 2017, Mateescu, an animal geneticist at the university, has been part of a team studying heat and humidity tolerance in breeds like Brahman and Brangus (a mix between Brahman and Angus cattle). Her aim is to identify the genetic markers that contribute to a breeds climate resilience, markers that might lead to more precise breeding and gene-editing practices.

In the South, Mateescu says, heat and humidity are a major problem. That poses a stress to the animals because theyre selected for intense productionto produce milk or grow fast and produce a lot of muscle and fat.

Like Nelore cattle in South America, Brahman are well-suited for tropical and subtropical climates, but their high tolerance for heat and humidity comes at the cost of lower meat quality than other breeds. Mateescu and her team have examined skin biopsies and found that relatively large sweat glands allow Brahman to better regulate their internal body temperature. With funding from the USDAs National Institute of Food and Agriculture, the researchers now plan to identify specific genetic markers that correlate with tolerance to tropical conditions.

If were selecting for animals that produce more without having a way to cool off, were going to run into trouble, she says.

There are other avenues in biotechnology beyond gene editing that may help reduce the cattle industrys footprint. Although still early in their development, lab-cultured meats may someday undermine todays beef producers by offering consumers an affordable alternative to the conventionally grown product, without the animal welfare and environmental concerns that arise from eating beef harvested from a carcass.

Other biotech techniques hope to improve the beef industry without displacing it. In Switzerland, scientists at a startup called Mootral are experimenting with a garlic-based food supplement designed to alter the bovine digestive makeup to reduce the amount of methane they emit. Studies have shown the product to reduce methane emissions by about 20 percent in meat cattle, according to the New York Times.

In order to adhere to the Paris climate agreement, Mootrals owner, Thomas Hafner, believes demand will grow as governments require methane reductions from their livestock producers. We are working from the assumption that down the line every cow will be regulated to be on a methane reducer, he told the New York Times.

Meanwhile, a farm science research institute in New Zealand, AgResearch, hopes to target methane production at its source by eliminating methanogens, the microbes thought to be responsible for producing the greenhouse gas in ruminants. The AgResearch team is attempting to develop a vaccine to alter the cattle guts microbial composition, according to the BBC.

Genomic testing may also allow cattle producers to see what genes calves carry before theyre born, according to Mateescu, enabling producers to make smarter breeding decisions and select for the most desirable traits, whether it be heat tolerance, disease resistance, or carcass weight.

Despite all these efforts, questions remain as to whether biotech can ever dramatically reduce the industrys emissions or afford humane treatment to captive animals in resource-intensive operations. To many of the industrys critics, including environmental and animal rights activists, the very nature of the practice of rearing livestock for human consumption erodes the noble goal of sustainable food production. Rather than revamp the industry, these critics suggest alternatives such as meat-free diets to fulfill our need for protein. Indeed, data suggests many young consumers are already incorporating plant-based meats into their meals.

Ultimately, though, climate change may be the most pressing issue facing the cattle industry, according to Telugu of the University of Maryland, which received a grant from the Bill and Melinda Gates Foundation to improve productivity and adaptability in African cattle. We cannot breed our way out of this, he says.

This article was originally published on Undark. Read the original article.

Image Credit: RitaE from Pixabay

View original post here:
Biotechnology Could Change the Cattle Industry. Will It Succeed? - Singularity Hub

Read More...

Boundless Bio Announces Publication in Nature Genetics Detailing the Association Between Extrachromosomal DNA-Based Oncogene Amplification and Poor…

August 18th, 2020 9:00 am

SAN DIEGO--(BUSINESS WIRE)--Boundless Bio, a company developing innovative new therapies directed to extrachromosomal DNA (ecDNA) in aggressive cancers, today announced research published in the journal Nature Genetics that demonstrates that ecDNA-based oncogene amplification drives poor outcomes for patients across many cancer types.

The manuscript, Frequent extrachromosomal oncogene amplification drives aggressive tumors, was co-authored by Boundless Bio scientists Nam-phuong Nguyen, Ph.D., and Kristen Turner, Ph.D., and scientific founders Paul Mischel, M.D., Distinguished Professor at the University of California San Diego (UC San Diego) School of Medicine and a member of the Ludwig Institute for Cancer Research; Vineet Bafna, Ph.D., Professor of Computer Science & Engineering, UC San Diego; Howard Chang, M.D., Ph.D., Virginia and D.K. Ludwig Professor of Cancer Genomics and Genetics, Stanford University; and Roel Verhaak, Ph.D., Professor and Associate Director of Computational Biology, The Jackson Laboratory.

The researchers used intensive computational analysis of whole-genome sequencing data from more than 3200 tumor samples in The Cancer Genome Atlas (TCGA) and the Pan-Cancer Analysis of Whole Genomes (PCAWG), totaling over 400 TB of raw sequencing data, to observe the impact of ecDNA amplification on patient outcomes. The researchers observed that ecDNA amplification occurs in many types of cancers, but not in normal tissue or in whole blood, and that the most common recurrent oncogene amplifications frequently arise on ecDNA. Notably, ecDNA-based circular amplicons were found in 25 of 29 cancer types analyzed, and at high frequency in many cancers that are considered to be amongst the most aggressive histological types, such as glioblastoma, sarcoma, and esophageal carcinoma. In addition, patients whose cancers carried ecDNA had significantly shorter survival, even when controlled for tissue type, than patients whose cancers were not driven by ecDNA-based oncogene amplification.

The findings demonstrate that ecDNA play a critical role in cancer, providing a mechanism for achieving and maintaining high copy number oncogene amplification and genetic heterogeneity while driving enhanced chromatin accessibility and elevating oncogene transcription. ecDNA amplifications are associated with aggressive cancer behavior, potentially by providing tumors with additional routes to circumvent current treatments and other evolutionary bottlenecks. The shorter overall survival, even when stratified by tumor type, raises the possibility that cancer patients whose tumors are driven by ecDNA may not be as responsive to current therapies and may be in need of new forms of treatment.

This important study builds on our rapidly expanding knowledge about ecDNA, showing, for the first time, that ecDNA amplifications are present in a broad range of cancer tumor types, said Jason Christiansen, Ph.D., Chief Technology Officer of Boundless Bio. These results point to the urgent need for therapies that can target ecDNA and interfere with their ability to drive aggressive cancer growth, resistance, and recurrence.

By detecting and characterizing the role that ecDNA play in driving hard-to-treat cancers, we are drawing a more accurate map of the cancer genome, said Dr. Mischel. It is our goal to take these findings and apply them to the development of powerful anti-cancer therapies for individuals with ecDNA-driven cancers.

About ecDNA

Extrachromosomal DNA, or ecDNA, are distinct circular units of DNA containing functional genes that are located outside cells chromosomes and can make many copies of themselves. ecDNA rapidly replicate within cancer cells, causing high numbers of oncogene copies, a trait that can be passed to daughter cells in asymmetric ways during cell division. Cancer cells have the ability to upregulate or downregulate oncogenes located on ecDNA to ensure survival under selective pressures, including chemotherapy, targeted therapy, immunotherapy, or radiation, making ecDNA one of cancer cells primary mechanisms of recurrence and treatment resistance. ecDNA are rarely seen in healthy cells but are found in many solid tumor cancers. They are a key driver of the most aggressive and difficult-to-treat cancers, specifically those characterized by high copy number amplification of oncogenes.

About Boundless Bio

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

For more information, visit http://www.boundlessbio.com.

Follow us on LinkedIn and Twitter.

About Boundless Bios Spyglass Platform

Boundless Bios Spyglass platform is a comprehensive suite of proprietary ecDNA-driven and pair-matched tumor models along with proprietary imaging and molecular analytical tools that enables Boundlesss researchers to interrogate ecDNA biology to identify a pipeline of novel oncotargets essential to the function of cancer cells that are enabled by ecDNA. The Spyglass platform facilitates Boundless innovation in the development of precision therapeutics specifically targeting ecDNA-driven tumors, thereby enabling selective treatments for patients whose tumor genetic profiles make them most likely to benefit from our novel therapeutic candidates.

See the article here:
Boundless Bio Announces Publication in Nature Genetics Detailing the Association Between Extrachromosomal DNA-Based Oncogene Amplification and Poor...

Read More...

Unless true origin of coronavirus is identified, another Chinese pandemic is in the offing – WION

August 18th, 2020 9:00 am

To date, no one has stated the urgent universal need to aggressively investigate the true origin of SARS-CoV-2, the coronavirus responsible for COVID-19, better than Karl and Dan Sirotkin in their August 12, 2020 article Might SARSCoV2 Have Arisen via Serial Passage through an Animal Host or Cell Culture?

Despite claims from prominent scientists that SARSCoV2 indubitably emerged naturally, the etiology of this novel coronavirus remains a pressing and open question: Without knowing the true nature of a disease, it is impossible for clinicians to appropriately shape their care, for policymakers to correctly gauge the nature and extent of the threat, and for the public to appropriately modify their behaviour.

As the authors correctly note, serial passage, that is, the repeated re-infection within an animal or human population allows a virus to specifically adapt to the infected species.

That process occurs naturally in the wild, but it can be greatly accelerated in the laboratory by deliberate serial passaging of viruses in cell culture systems or animals, potentially leaving few or no traces as to whether the adapted viruses are naturally-occurring or laboratory-manipulated.

That type of "gain of function" experimentation can become particularly dangerous if viruses are adapted for human infection by serial passaging them through cell cultures and animal models that have been genetically-modified to express human receptors.

There are numerous scientific publications describing serial passaging of coronaviruses through humanised cell cultures and animal models, thus potentially creating a new coronavirus pre-adapted for human infection.

At present, the scientific consensus is that SARS-CoV-2 came from bats, but how it evolved to infect humans remains unknown.

China has claimed that a bat coronavirus named RaTG13 is the closest relative to SARS-CoV-2, but RaTG13 is not actually a virus because no biological samples exist. It is only a genomic sequence of a virus for which there are now serious questions about its accuracy.

In contrast, Dr Li-Meng Yan, a Chinese virologist and whistleblower, has implied that RaTG13 may have been used to divert the worlds attention away from the true source of the COVID-19 pandemic, a novel coronavirus that originated in military laboratories overseen by China's Peoples Liberation Army and created by the manipulation of Zhoushan coronaviruses ZC45 and/or ZXC21.

SARS-CoV-2 has signs of serial passaging and the direct genetic insertion of novel amino acids sequences for which no natural evolutionary pathway has been identified.

Although SARS-CoV-2 appears to have the backbone of bat coronaviruses, its spike protein, which is responsible for binding to the human cell and its membrane fusion-driven entry, has sections that do not appear in any closely-related bat coronaviruses.

SARS-CoV-2s receptor binding domain, the specific element that binds to the human cell, has a ten times greater binding affinity than the first SARS virus that caused the 2002-2003 pandemic.

Furthermore, SARS-CoV-2 appears to be pre-adapted for human infection and has not undergone a similar natural mutation process within the human population that was observed during the 2002-2003 SARS outbreak.

Those observations plus the inexplicable genetic distance between SARS-CoV-2 and any of its potential bat predecessors suggest an accelerated evolutionary process obtained by laboratory-based serial passaging through genetically-engineered mouse models containing humanised receptors previously developed by China.

The other unique feature of SARS-CoV-2 is a furin polybasic cleavage site that facilitates membrane fusion between the virus and the human cell and widely known for its ability to enhance pathogenicity and transmissibility, but also is not present in any closely related bat coronaviruses.

There are no readily-available animal models to produce a unique furin polybasic cleavage site by serial passaging, but techniques for the artificial insertion of such furin polybasic cleavage sites by genetic engineering have been used for over ten years.

To paraphrase Karl and Dan Sirotkin, unless the zoonotic hosts necessary for completing a natural jump from animals to humans are identified, the dualuse gainoffunction research practice of viral serial passage and the artificial insertion of unique viral features should be considered viable routes by which SARS-CoV-2 arose and the COVID-19 pandemic was initiated.

Lawrence Sellin, PhD is a retired US Army Reserve colonel. He has previously worked at the US Army Medical Research Institute of Infectious Diseases and conducted basic and clinical research in the pharmaceutical industry. His email address is lawrence.sellin@gmail.com.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL.)

Go here to read the rest:
Unless true origin of coronavirus is identified, another Chinese pandemic is in the offing - WION

Read More...

SinoPharm’s Inactivated Coronavirus Vaccine | In the Pipeline – Science Magazine

August 18th, 2020 9:00 am

So now we have some clinical data on yet another category of vaccine: SinoPharms inactivated coronavirus candidate. This is one of the classic vaccine techniques, where an infectious virus is altered by some sort of protein-denaturing treatment (heating or reactive chemistry) to make it noninfectious. But such particles can retain enough of their protein surfaces to set off a useful immune response the tricky part is inactivating the virus enough so that it cant infect cells and replicate, but not so much that it presents totally different proteins to the immune system and raises a response that wont help against the real virus.

In SinoPharms case, they inactivated the coronavirus with beta-propiolactone, which is a classic protein-alkylating compound. BPL is a strained four-membered ring that is ready to be attacked and opened by pretty much any sort of nucleophile, including protein side chains from amino acids such as Cys or Lys. The compound is used for chemical disinfection (surgical instruments and the like), but thats not a casual application, because its carcinogenic by itself. It works out for such applications, though, because its very volatile (and thus easy to remove by vacuum or heating), much like another small reactive and toxi) strained ring compound, ethylene oxide. So theres no danger in using BPL to inactivate a virus the question, as mentioned, is going to be whether youve inactivated it too much.

Patients in the Phase I trial got 2.5, 5, or 10 micrograms of this agent at Day 0, Day 28, and a third time at Day 56. There were 24 patients in each group, plus an equal-sized placebo group that just got alum adjuvant injections. In the Phase II trial, the 5 microgram dose was chosen, and there were two groups: injection at Day 0 and Day 14, or injection at Day 0 and Day 21, with 84 patients in each group and a 28-patient placebo group for each. Median ages were around the early 40s, slightly more men than women. Adverse reactions appear to have been nothing remarkable pain at the injection site mostly, with very little systemic stuff like fever or fatigue, which certainly appears to be the mildest profile of the vaccines that weve seen so far.

As for neutralizing antibodies, it looks like the three-dose Phase I trial had an odd dose-response. The medium dose was actually slightly worse than either the low or high one. Meanwhile, in the Phase II, which was done with that medium five-microgram dose, the antibody response (measured two weeks after the second dose) was not as strong as with the full three-dose schedule, but the 0/21 day dosing schedule led to a better response than the 0/14 one. It appears from the Phase II data that one of the 42 patients who were tested for antibody response in that group did not seroconvert at all. The geometric mean titer values for the neutralizing antibodies (247 for the 0/21 group) appear to be in the range of other Phase I data reported, although its not easy to make a head-to-head comparison with any certainty. There is no comparison in the study with a convalescent plasma group, but as weve been seeing, those samples tend to be pretty variable themselves. There are also no data on T-cell responses.

So this is a rather preliminary report (as the authors themselves note), but its the first one we have on an inactivated vaccine. Like all of the others so far except the J&J Ad26 one, this candidate will also need a booster shot. The small and mild adverse-event reactions here are really the main thing that stands out if youre a glass half full person, then you can be glad about that, but if youre a glass-half-empty one, you might wonder about the overall robustness of the immune response. Were going to need more data to make any calls about that, and (just as with every other vaccine under development!) the real numbers were waiting on for efficacy. How many people will this (or any) vaccine protect, and how well? Stay tuned.

Read more:
SinoPharm's Inactivated Coronavirus Vaccine | In the Pipeline - Science Magazine

Read More...

Protein Expression Technology Market is anticipated to record a CAGR of around 10% over the forecast period ie 2019-2027 – Scientect

August 18th, 2020 9:00 am

A new report published by Research nester, titledProtein Expression Technology Market: Global Demand Analysis & Opportunity Outlook 2027delivers detailed overview of the global protein expression technology marketin terms of market segmentation by expression system, by application, by end user and by region.

Based on expression systems, the global protein expression technology market is segmented into prokaryotic, insect, mammalian, yeast and others; by application into drug discovery, protein purification, protein-protein interaction, disease diagnostics & monitoring and others; by end user into pharmaceutical companies, biotechnology companies, academic research and others.

The global protein expression technology market is anticipated to record a CAGR of around 10% over the forecast period i.e. 2019-2027.

Protein expression is among the most fundamental biological processes. It refers to processes which describe how living cells or organisms synthesize, modify and regulate proteins. Expression of a protein includes three processes, namely, transcription, translation and post-translational modification. These processes play a vital role in the expression of a gene and its regulation. Increasing investment for R & D development by pharmaceutical and biotechnology companies along with rising demand for therapeutic proteins for the treatment of various ailments is anticipated to propel the growth of the market over the forecast period. Additionally, one major advantage of protein and gene expression is the ability to detect both hereditary and environmental abnormalities of a given disease, if linked to disease presentation. This is also projected to positively impact the growth of the market.

Furthermore, application of soluble receptors, monoclonal antibodies, engineered proteins, peptides, and their conjugates as drugs is expected to drive the growth of the market.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Request for a sample of this research report @https://www.researchnester.com/sample-request-679

On the basis of region, the global protein expression technology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to witness a significant growth during the forecast period on the back of technological advancements for the manufacturing and research of personalized medicine with the help of proteomics. Moreover, funding provided by various governmental and non-governmental organizations for research in this region is also expected to foster the growth of market. The market in Asia Pacific is also estimated to show a considerable growth over the forecast period owing to the increased prevalence of chronic diseases due to sedentary lifestyle of people.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Download Sample Report Here:https://www.researchnester.com/sample-request-679

Application of Therapeutic Protein in Medicine

Most of the human diseases are in some way related to dysfunction of a specific protein. Therapeutic protein produced by the protein expression technology provides treatment for a variety of diseases, such as diabetes, cancer, hemophilia, infectious diseases, and anemia. These proteins formed by recombinant technology and genetic engineering have wide array of applications in medicine. A few common therapeutic proteins are FC fusion proteins, hormones, interleukins, enzymes, anticoagulants, and others. Thus, the application of these therapeutic protein in medicine for the remedy of the numerous diseases is anticipated to propel the growth of the market.

However, high cost involved with the research of expression proteins along with stringent regulation and policies for their approval as drugs are expected to operate as a key restraint to the growth of the global protein expression technology market over the forecast period.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porters five force model.

This reportalso provides the existing competitive scenario of some of the key players of the global protein expression technology market which includes company profiling of Thermo Fisher Scientific Inc., Merck KGaA, Promega Corporation, Agilent Technologies, GenScript, Takara Holdings Inc., Bio-Rad Laboratories Inc., Qiagen, Lonza and other prominent players. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global protein expression technology marketthat will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).

Request Report [emailprotected]https://www.researchnester.com/sample-request-679

About Research Nester

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

For More Update Follow-LinkedIn|Twitter|Xing

Contact for more Info:

AJ Daniel

Email:[emailprotected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Read More Related Reports:

Metal Packaging MarketConveyor Ovens MarketCommercial Aircraft Wing MarketAutomotive Carbon Wheels MarketDefense Fuel Cell MarketGyro Compass MarketTranscatheter Aortic Valve Replacement System MarketExpanded Perlite MarketShoe Packaging MarketSolar Equipment MarketSmart Switches MarketMicroscope digital cameras MarketAutomotive Door Stabilizer MarketSport Cap And Closure MarketDemulsifier Market

Original post:
Protein Expression Technology Market is anticipated to record a CAGR of around 10% over the forecast period ie 2019-2027 - Scientect

Read More...

Engineered COVID-19-Infected Mouse Bites Researcher Amid ‘Explosion’ of Risky Coronavirus Research – CounterPunch

August 18th, 2020 9:00 am

Photograph by Nathaniel St. Clair

University researchers genetically engineer a human pandemic virus. They inject the new virus into a laboratory mouse. The infected mouse then bites a researcher..It is a plot worthy of a Hollywood blockbuster about risky coronavirus research.

But according to newly obtained minutes of the Institutional Biosafety Committee (IBC) of the University of North Carolina (UNC), Chapel Hill, these exact events need not be imagined. They occurred for real between April 1st and May 6th this year.

The identity of the bitten coronavirus researcher has not been revealed except that they were working in a high security BSL-3 virus lab when the accident happened.

According to Richard Ebright, an epidemiologist from Rutgers University, the UNC incident underscores an important development in virus research since the pandemic began:

There has been an explosion of research involving fully infectious SARS-CoV-2 over the last six months.Research with infectious SARS-CoV-2 now is occurring in every, or almost every, BSL-3 facility in the US and overseas.

This strong upsurge is affirmed by Edward Hammond of Prickly Research, Austin, TX, former Director of the Sunshine Project, an NGO that tracked the post 9/11 expansion of the US Biodefense program.

It is evident that swarms of academic researchers with little prior experience with coronaviruses have leapt into the field in recent months.

For Hammond, this explosion represents a hazard:

We need to be clear headed about the risk. The first SARS virus was a notorious source of laboratory-acquired infections and there is a very real risk that modified forms of SARS-CoV-2 could infect researchers, especially inexperienced researchers, with unpredictable and potentially quite dangerous results. The biggest risk is the creation and accidental release of a novel form of SARS-CoV-2 a variant whose altered characteristics might undermine global efforts to stop the pandemic by evading the approaches being taken to find COVID vaccines and treatments.

And, continues Hammond: Each additional lab that experiments with CoV-2 amplifies the risk.

Richard Ebright concurs, telling Independent Science News in an email that this research is:

in many cases being performedbyresearchers who have no prior experience in BSL-3 operations and pathogens research, and who therefore pose elevated risk of laboratory accidents withBSL-3 pathogens.

Ebright is also concerned that some influential experimenters are now calling for reduced oversight:

The UNC incident also underscores that calls by some, notably Columbia University virologist Vincent Racaniello (Podcast at 01:35mins onwards), to allow virus-culture and virus-production research with fully infectious SARS-CoV-2 at BSL-2 are egregiously irresponsible and absolutely unacceptable.

Other researchers are also calling for restraint. In a paper titled Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus, researchers from China and the US critiqued the synthesis in February of a full length infectious clone (Gao et al., 2020; Thao et al., 2020). And, in concluding, these researchers asked a question that is even more pertinent now than then Once the risks [of a lab escape] become a reality, who or which organization should take responsibility for them?

The accident at the University of North Carolina (UNC) is now in the public domain but only thanks to a FOIA request submitted by Hammond (in line with NIH guidelines) and shared with Independent Science News.

Despite the FOIA request, apart from the fact that UNC classified it as an official Reportable Incident, i.e. that must be reported to National Institutes of Health (NIH) in Washington DC, scarcely any information about the accident is available.

In part this is because the minutes of the relevant IBC meeting (May 6th, 2020, p109) are extremely brief. They do not provide any details of the fate of the bitten researcher. Nor do they state, for example, whether the researcher developed an active infection, nor whether they developed symptoms, nor if they transmitted the recombinant virus to anyone else. Neither do they reveal what kind of recombinant virus was being used or the purpose of the experiment.

To try to learn more, Independent Science News emailed the lab of Ralph Baric at UNC, which, based on their research history is the most likely coronavirus research group involved (Roberts et al., 2007; Menachery et al., 2015), the University Biosafety Officer, and UNC Media relations.

Only the latter replied:

The April 2020 incident referred to in the University Institutional Biosafety Committee meeting minutes involved a mouse-adapted SARS-CoV-2 strain used in the development of a mouse model system.

Ralph Baric UNC Gillings School of Public Health-web.

The researcher did not develop any symptoms and noinfection occurredas a result of the incident.

Our questions in full and the full UNC reply are available here.

The second reason for this lack of information is that the UNC redacted the names of Principal Investigators (PIs) whose research required biosafety scrutiny, along with many of the experimental specifics.

Nevertheless, unredacted parts of minutes from IBC meetings held in 2020 contain descriptions of experiments that potentially encompass the accident. They include:

Application 75223:

(a full-length infectious clone refers to a viable DNA copy of the coronavirus, which is ordinarily an RNA virus)

and

Application 73790:

and

Application 74962:

In all, any one of eight sets of different experiments approved by the UNC Chapel Hill IBC in 2020 proposed infecting mice with live infectious and mutant SARS-CoV-2-like coronaviruses under BSL-3 conditions and therefore could have led to the accident.

According to Hammond the lack of transparency represented by the sparse minutes and especially the redactions represent a violation of sciences social contract:

At the dawn of recombinant DNA, at the request of the scientific community itself, following the fabled Asilomar conference, the United States government took the position of not regulating genetic engineering in the lab. The deal that big science struck with the government was that, in return for not being directly regulated, principal investigators would take personal responsibility for lab biosafety, involve the public in decision-making, and accept public accountability for their actions.

The NIH Guidelines and Institutional Biosafety Committee system of self-regulation by researchers is founded upon the principal of personal responsibility of PIs and the promise of transparency. The redaction of the researchers identities from IBC meeting minutes, in order to hide the activities of researchers and avoid accountability for accidents, fundamentally contradicts the core principles of the US oversight system and violates the commitments that science made.

Richard Ebright goes further:

There is no justification for UNCs redactionof the names of the laboratory heads andthe identities of pathogens. UNCs redactions violate conditions UNC agreed to in exchange for NIH funding of UNCs research and, if not corrected, should result in the termination of current NIH funding, and the loss of eligibility for future NIH funding, of UNCs research.

Are universities doing too many risky experiments on coronaviruses?

The second concern of researchers contacted by Independent Science News is that unnecessary and dangerous experiments will be conducted as a result of the COVID-19 pandemic. According to Richard Ebright:

The UNC incident shows that serious laboratory accidents with SARS-CoV-2can occur even in a lab having extremely extensive experience in BSL-3 operations and unmatched expertise in coronavirus research, and underscores the risks associated with uncontrolled proliferation of research on SARS-CoV-2, especially for labs lacking prior experience in BSL-3 operations and coronavirus research.

For this reason Ebright argues that:

It is essential that a national needs-assessment and biosafety assessment be performed for research involving fully infectious SARS-CoV-2. It also is essential that a risk-benefit review be performed before approving research projects involving fully infectious SARS-CoV-2something that currently does not occurto ensure that potential benefits to the public outweigh the real risks to laboratory workers and the public.

This concern over risks and benefits is shared by Edward Hammond. Using FOIA again he has further discovered that researchers at the University of Pittsburgh (whose identity is redacted) plan to make what Hammond calls Corona-thrax.

In short, according to its Institutional Biosafety Committee, Pittsburgh researchers intend put the spike protein of SARS-CoV-2 (which allows the virus to gain entry into human cells) into Bacillus anthracis which is the causative agent of anthrax.

The anthrax strain proposed to be used for this experiment is disarmed but, Hammond agrees with Gao et al., (2020) that the balance of risks and benefits appears not to be receiving adequate consideration.

This experiment was nevertheless approved by the Institutional Biosafety Committee of the University of Pittsburgh. But by redacting the name of the laboratory from the minutes and also every name of the members of the committee which approved it, the University has supplied a de facto response to the final question posed by Gao et al.: who will take responsibility for risky coronavirus research?

References

Gao, P., Ma, S., Lu, D., Mitcham, C., Jing, Y., & Wang, G. (2020). Prudently conduct the engineering and synthesis of the SARS-CoV-2 virus.Synthetic and systems biotechnology,5(2), 59-61.Menachery, V. D., Yount, B. L., Debbink, K., Agnihothram, S., Gralinski, L. E., Plante, J. A., & Randell, S. H. (2015). A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nature medicine,21(12), 1508-1513.Roberts, A., Deming, D., Paddock, C. D., Cheng, A., Yount, B., Vogel, L., & Zaki, S. R. (2007). A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.PLoS Pathog,3(1), e5.Thao, T. T. N., Labroussaa, F., Ebert, N., Vkovski, P., Stalder, H., Portmann, J., & Gultom, M. (2020). Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform.BioRxiv.

This article first appeared in Independent Science News.

Read more here:
Engineered COVID-19-Infected Mouse Bites Researcher Amid 'Explosion' of Risky Coronavirus Research - CounterPunch

Read More...

Make way for sustainable, healthy and delicious food! – Innovation Origins

August 18th, 2020 9:00 am

Vitamin B12 is only found in animal proteins, i.e. in meat and dairy. This is why vegans often take supplements in order to get the amount they need. A sustainable diet implies eating less animal protein, as the Netherlands Nutrition Centre (Stichting Voedingscentrum) also recommends. But how can we make sure that our sustainable food is both healthy and delicious?

According to Corn van Dooren, nutritionist and expert on sustainable eating at the Netherlands Nutrition Centre, this is the key question for the future. A liter of cola has less environmental impact than a liter of milk. Of course, that doesnt mean that you are better off drinking cola because it doesnt provide any nutrients. In Van Doorens opinion, you have to look at sustainable food in a variety of ways: You cant do without food, but you can do without flying. Get your food close to home and in season.

In 2018, Van Dooren earned his PhD on the topic of how sustainable (as in, environmental impact) and healthy (as in, nutritional quality) existing dietary patterns are. He devised the Sustainable Nutrient-Rich Food index, a mathematical model that offers nutritional advice. He divided products into four categories: red, white, brown, and green. Van Dooren: The green category comprising vegetables, mushrooms, legumes, soy products, and fruit, for example, scores the highest on both aspects sustainability and healthy nutritional value. The model also shows, in addition to the composition of a product, where it was grown and how its sustainability is assessed, Van Dooren explains.

The Wheel of Five is a guideline for healthy food in the Netherlands, but it does not yet include a sustainable index. The last update of the wheel was made in 2016. It stated: eat more vegetables (from 200 grams to 250 grams per day), less meat (maximum 500 grams per week), and eat more plant-based foods, such as a weekly portion of legumes and a handful of nuts every day. Those 500 grams could be discussed from a sustainability perspective, because in that case, perhaps meat once or twice per week would then be the most optimal option.

If you eat the maximum amount of 500 grams of protein per week, then the ratio of animal and vegetable protein is 50/50. If you eat almost no meat as part of the Wheel of Five, but you do eat dairy, egg, and fish, then you end up with a ratio of 40/60. On average, Dutch people now get 61% of their protein from animal sources and 39% from plant-based sources. According to the Dutch Council for the Environment and Infrastructure, RLi), this figure needs to be reversed by 2030. This means that the percentage of animal protein in our diet must then be reduced to 40% of our total protein consumption.

In that whole protein transition, as we like to call the offer of alternatives to meat, there was Finnish research into vitamin B12 that can, of course, help people take that step more easily. In any case, Van Dooren regards fermentation, which the Finnish researchers used, as an interesting and exciting innovative development: We should take a closer look into areas around small organisms, such as bacteria, fungi, yeasts, and algae, and see what can be gained from that.

Fermentation is by no means new. It is mainly known for ensuring that vegetables, fruit, fish, and dairy products have a longer shelf life. It is a natural process, also known as controlled fermentation, which can also provide new flavors and products that have plenty of nutritional value. For instance, microbiologist Professor. Dr. Eddy Smit at Wageningen University has cultured tempeh from fermented lupine beans. Apparently, there is as much vitamin B12 in that as there is in a piece of steak.

The greatest voyage of discovery to come lies in the combination of common nutrients with existing natural products, Van Dooren believes: What we know is that legumes and bacteria work together in removing nitrogen from the air. As a consequence, you would no longer need artificial fertilizer. It would be extremely interesting if you were able to combine those kinds of interactions with other plants.

That you can use that particular characteristic of legumes in other crops is also very exciting news for Van Dooren. You end up with a technology that is very far-reaching, albeit not universally accepted. It will have to be done using genetic engineering, which is something that a proportion of consumers will not accept.

Of course, the flavor is also important when it comes to gaining acceptance for meat and dairy substitutes, Van Dooren adds. Soy, for example, is the closest thing to dairy in terms of nutritional value, but it tastes completely different. The German company Made With Luve makes dairy substitutes using lupine. This is a crop that can grow very well in northwestern Europe, which is also a major advantage. Soy is difficult to grow here.

Step by step, sustainable and healthy food is coming ever-closer. Van Dooren considers that true change will still take some time: Now the main emphasis of current innovations is to ensure that meat substitutes are as similar in taste and texture to meat as possible. That they produce the same sensation as meat. The real innovation will be, of course, when a new generation comes along that spurs us on to forget about meat altogether. That is making products that are so special and which have a totally new flavor sensation that transcends the taste of meat.

The rest is here:
Make way for sustainable, healthy and delicious food! - Innovation Origins

Read More...

Bringing Peer Review To Early COVID-19 Research, More News – Bio-IT World

August 18th, 2020 8:59 am

August 18, 2020| New insights into the SARS-CoV-2 spike protein, a daily aerosol protectant, a look a death rates in 1918 and now, and a journal dedicated to publishing COVID-19 research with visible peer review. Plus new funding from NIH and the American Heart Association to enable further research on SARS-CoV-2 and COVID-19.

Research Updates

Using nanometer-level simulations, Northwestern Universityresearchers have discovered a positively charged site (known as the polybasic cleavage site) located 10 nanometers from the actual binding site on the SARS-CoV-2 spike protein. The positively charged site allows strong bonding between the virus protein and the negatively charged human-cell receptors. Leveraging this discovery, the researchers designed a negatively charged molecule to bind to the positively charged cleavage site. Blocking this site inhibits the virus from bonding to the host cell. The work was published in ACS Nano. DOI: 10.1021/acsnano.0c04798

UC San Franciscoscientists have devised a novel approach to halting the spread of SARS-CoV-2: a completely synthetic, production-ready molecule that straitjackets the crucial SARS-CoV-2 machinery that allows the virus to infect our cells. As reported in a new paper, now available on the preprint server bioRxiv, experiments using live virus show that the molecule is among the most potent SARS-CoV-2 antivirals yet discovered. In an aerosol formulation they tested, dubbed AeroNabs by the researchers, these molecules could be self-administered with a nasal spray or inhaler. Used once a day, AeroNabs could provide powerful, reliable protection against SARS-CoV-2 until a vaccine becomes available, they say. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs. If these tests are successful, the scientists aim to make AeroNabs widely available as an inexpensive, over-the-counter medication to prevent and treat COVID-19. Preprint DOI: 10.1101/2020.08.08.238469

Researchers from Harvard, Yale, and Emorycompared the estimated excess deaths in New York during the peak of the 1918 influenza pandemic with above-average deaths during the early period of the COVID-19 outbreak in a new research letter published in JAMA Network Open. During the peak of the 1918 H1N1 influenza outbreak in New York City, a total of 31,589 all-cause deaths occurred among 5,500,000 residents, yielding an incident rate of 287.17 deaths per 100,000 person-months. During the early period of the COVID-19 outbreak in New York City, 33,465 all-cause deaths occurred among 8,280,000 residents, yielding an incident rate of 202.08 deaths per 100,000 person-months. These findings suggest that the mortality associated with COVID-19 during the early phase of the New York City outbreak was comparable to the peak mortality observed during the 1918 H1N1 influenza pandemic, the authors write. DOI: 10.1001/jamanetworkopen.2020.17527

A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapyat Houston Methodist suggests the treatment is safe and effective. The results appear in The American Journal of Pathology. The study compared 316 transfused patients to controls and preliminary analysis showed a significant reduction in mortality within 28 days, specifically in patients transfused within 72 h of admission with plasma with an anti-spike protein receptor binding domain titer of 1:1350. DOI: 10.1016/j.ajpath.2020.08.001

A team from Yale conducted a retrospective cohort study of 1827 patients with confirmed COVID19 who were hospitalized within the YaleNew Haven Health System (YNHHS) between March 14, 2020 and April 23, 2020 and published their findings in Hepatology. They analyzed liver tests at three time points (preinfection baseline, admission, peak hospitalization), and hospitalization outcomes (severe COVID19, ICU admission, mechanical ventilation, death). Abnormal liver testswere commonly observed in hospitalized patients with COVID19, both at admission and peak hospitalization. A significant proportion of these patients had abnormal liver tests prehospitalization. Multivariate analysis revealed an association between abnormal liver tests and severe COVID19, including ICU admission, mechanical ventilation, and death. DOI: 10.1002/hep.31487

An online national survey of 4, 351 adolescents and young adults aged 1324 years was conducted in May 2020 and used to assess relationships among COVID-19 and e-cigarettes and cigarettes. Researchers from Stanford found that COVID-19 was five times more likely among ever-users of e-cigarettes only, seven times more likely among ever-dual-users, and 6.8 times more likely among past 30-day dual-users. The team published their findings in the Journal of Adolescent Health and concluded that COVID-19 is associated with youth use of e-cigarettes only and dual use of e-cigarettes and cigarettes, suggesting the need for screening and education. DOI: 10.1016/j.jadohealth.2020.07.002

Researchers from Harvard and Washington Universityhave constructed chimeric forms of vesicular stomatitis virus (VSV) bearing the fusion proteins of Zaire ebolavirus (ZEBOV) or SARS coronavirus 2 (SARS-CoV-2) and shown that two small-molecule inhibitors of an endosomal lipid kinase (PIKfyve) inhibit viral infection by preventing release of the viral contents from endosomes. The findings suggest the potential for targeting PIKfyve kinase when developing small-molecule antivirals against SARS-CoV-2. The results were published in PNAS. DOI: 10.1073/pnas.2007837117

By applying the renewal theory in probability to reduce recall bias in initial case reports, scientists from NIH, Peking University, and the Chinese Center for Disease Controland Prevention have come up with a new estimate for the incubation periodof COVID-19. Their mean estimate of 7.76 days, longer than previous estimates of 4 to 5 days, is based on 1,084 confirmed cases of COVID-19 that had known histories of travel or residency in Wuhan, China. The results were published in Science Advances, and the authors caution that their approach relies on several assumptions and may not apply to later cases where the virus may have mutated. DOI: 10.1126/sciadv.abc1202

Last month, a team from McMaster University analyzed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the FANTOM5 dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, proteomic datasets, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples. Their findings, published in the European Respiratory Journal, suggest the presence of a mechanism dynamically regulating ACE2 expression in human lung, perhaps in periods of SARS-CoV-2 infection, and also suggest that alternate receptors for SARS-CoV-2 exist to facilitate initial host cell infection. DOI: 10.1183/13993003.01123-2020Later in July, a group from Uppsala University came to a similar conclusion in a paper published in Molecular Systems Biology. In the respiratory system, the expression of ACE2 was limited, with no or only low expression in a subset of cells in a few individuals, observed by one antibody only, the Swedish group writes. DOI: 10.15252/msb.20209610

To compare disease trends in adults and childrenduring the first wave of the coronavirus pandemic in England between January and May 2020, UK researchers reviewed COVID-19 test result data for this period. The data included NHS and Public Health England (PHE) test results plus those carried out by family doctors at 300 general practices contributing to the Royal College of General Practitioners monitoring system for flu-like illness35,200 children under the age of 16. Around 24% of all those tested had the virus, and children accounted for 1% of the total. 4% of the 35,200 tests carried out on children were positive compared to 19%-35% of adults. Their findings are published in BJM. DOI: 10.1136/archdischild-2020-320042.

Evidence has revealed that SARS-CoV-2 infection caused taste lossat a rate higher than that of influenza. ACE2, the entry receptor of SARS-CoV-2, has been identified in the oral epithelium; however, it is unclear at what developmental stage ACE2 expression emerges and whether ACE2 is expressed in taste buds. To identify the specific developmental stage, researchers from the University of Georga analyzed RNA-Seq data from embryonic, newborn, and adult mouse oral tissue. They found that when applied across species, nongustatory papilla epithelial cells are the prime targets for SARS-CoV-2 infection in the tongue; thus, taste loss in COVID-19 patients is likely not caused by a direct infection of SARS-CoV-2 to taste bud cells. Additionally, fetuses at different stages of development may have distinct susceptibility to SARS-CoV-2 infection. Their results are published in ACS Pharmacology and Translational Science. DOI: 10.1021/acsptsci.0c00062

In Annals of Internal Medicine, researchers from Garibaldi Hospital in Italy describe what they believe are the first 3 reported cases of AChR antibodypositive myasthenia gravis after COVID-19. Their observations are consistent with reports of other infections that induce autoimmune disorders, they say, as well as with the growing evidence of other neurologic disorders with presumed autoimmune mechanisms after COVID-19 onset. The team notes that symptoms of myasthenia gravis appeared within 5 to 7 days after fever onset in all 3 patients, and the time from presumed infection with SARS-CoV-2 to the beginning of myasthenia gravis symptoms is consistent with the time from infection to symptoms in other neurologic disorders triggered by infections. DOI: 10.7326/L20-0845

Industry Updates

MIT Press and the University California, Berkeley have launched an open access journalRapid Reviews: COVID-19 (RR:C19)in an effort to reduce misinformation and to elevate noteworthy and useful research for scientists, public health officials, journalists, and the public. The first issue posted peer reviews of eight COVID-19 preprint studies. More than 20,000 preprints have been made available on preprint servers, including medRxiv, bioRxiv, and SSRN. The RR:C19 editorial team believes there is an urgent need for scholarly peer review to validateor debunkinformation before it is widely circulated. Press release.

The American Heart Associationhas awarded an additional $400,000 in research grants focused on the cardiovascular impact of COVID-19. The awards go to four more teams who submitted proposals for the COVID-19 and Its Cardiovascular Impact Rapid Response Grants during the original submission process in March. The winning teams come from Cleveland Clinic, Johns Hopkins University, Cedars-Sinai Medical Center, and New York-Presbyterian/Columbia University Irving Medical Center. Press release.

The National Institutes of Health has awarded a grant of $1.2 million to the Mouse Biology Programat the University of California, Davis, to create mice that are susceptible to the COVID-19 virus, and to distribute them to researchers. Mice and rats are not naturally infected by SARS-CoV-2, the virus that causes COVID-19. The virus enters human cells by attaching to a protein called ACE2. Lloyd's team plans to create "humanized" laboratory mice by using CRISPR-Cas9 technology to precisely replace the genetic code for the mouse equivalent of ACE2 with the code for human ACE2. Press release.

Continued here:
Bringing Peer Review To Early COVID-19 Research, More News - Bio-IT World

Read More...

Jennifer.grey The Daily Chronicle – The Daily Chronicle

August 18th, 2020 8:59 am

The global Agricultural Balers market focuses on encompassing major statistical evidence for the Agricultural Balers industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition the Agricultural Balers study also shifts its attention with an in-depth competitive landscape, defined growth opportunities, market share coupled with product type and applications, key companies responsible for the production, and utilized strategies are also marked.

This intelligence and 2026 forecasts Agricultural Balers industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and sets a precedented growth trajectory for the Agricultural Balers market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Moreover, the Agricultural Balers report describes the market division based on various parameters and attributes that are based on geographical distribution, product types, applications, etc. The market segmentation clarifies further regional distribution for the Agricultural Balers market, business trends, potential revenue sources, and upcoming market opportunities.

Download PDF Sample of Agricultural Balers Market report @ https://hongchunresearch.com/request-a-sample/40306

Key players in the global Agricultural Balers market covered in Chapter 4:, Shen Yang Fang Ke, John Deere, Foton Lovol, An Yang Yu Gong, New Holland, Abbriata, Claas, Yulong Machinery, Kuhn, Krone, Case IH, Shanghai Star, Vermeer, Massey Ferguson, Minos

In Chapter 11 and 13.3, on the basis of types, the Agricultural Balers market from 2015 to 2026 is primarily split into:, Round Balers, Square Balers

In Chapter 12 and 13.4, on the basis of applications, the Agricultural Balers market from 2015 to 2026 covers:, Hay, Cotton, Straw, Silage, Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:, North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe (Covered in Chapter 7 and 13), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 8 and 13), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 9 and 13), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 10 and 13), Brazil, Argentina, Columbia, Chile, Others

The Agricultural Balers market study further highlights the segmentation of the Agricultural Balers industry on a global distribution. The report focuses on regions of North America, Europe, Asia, and the Rest of the World in terms of developing business trends, preferred market channels, investment feasibility, long term investments, and environmental analysis. The Agricultural Balers report also calls attention to investigate product capacity, product price, profit streams, supply to demand ratio, production and market growth rate, and a projected growth forecast.

In addition, the Agricultural Balers market study also covers several factors such as market status, key market trends, growth forecast, and growth opportunities. Furthermore, we analyze the challenges faced by the Agricultural Balers market in terms of global and regional basis. The study also encompasses a number of opportunities and emerging trends which are considered by considering their impact on the global scale in acquiring a majority of the market share.

The study encompasses a variety of analytical resources such as SWOT analysis and Porters Five Forces analysis coupled with primary and secondary research methodologies. It covers all the bases surrounding the Agricultural Balers industry as it explores the competitive nature of the market complete with a regional analysis.

Brief about Agricultural Balers Market Report with [emailprotected] https://hongchunresearch.com/report/agricultural-balers-market-40306

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Agricultural Balers Market

Chapter Four: Players Profiles

Chapter Five: Global Agricultural Balers Market Analysis by Regions

Chapter Six: North America Agricultural Balers Market Analysis by Countries

Chapter Seven: Europe Agricultural Balers Market Analysis by Countries

Chapter Eight: Asia-Pacific Agricultural Balers Market Analysis by Countries

Chapter Nine: Middle East and Africa Agricultural Balers Market Analysis by Countries

Chapter Ten: South America Agricultural Balers Market Analysis by Countries

Chapter Eleven: Global Agricultural Balers Market Segment by Types

Chapter Twelve: Global Agricultural Balers Market Segment by Applications12.1 Global Agricultural Balers Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Agricultural Balers Sales and Market Share by Applications (2015-2020)12.1.2 Global Agricultural Balers Revenue and Market Share by Applications (2015-2020)12.2 Hay Sales, Revenue and Growth Rate (2015-2020)12.3 Cotton Sales, Revenue and Growth Rate (2015-2020)12.4 Straw Sales, Revenue and Growth Rate (2015-2020)12.5 Silage Sales, Revenue and Growth Rate (2015-2020)12.6 Other Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Agricultural Balers Market Forecast by Regions (2020-2026) continued

Check [emailprotected] https://hongchunresearch.com/check-discount/40306

List of tablesList of Tables and FiguresTable Global Agricultural Balers Market Size Growth Rate by Type (2020-2026)Figure Global Agricultural Balers Market Share by Type in 2019 & 2026Figure Round Balers FeaturesFigure Square Balers FeaturesTable Global Agricultural Balers Market Size Growth by Application (2020-2026)Figure Global Agricultural Balers Market Share by Application in 2019 & 2026Figure Hay DescriptionFigure Cotton DescriptionFigure Straw DescriptionFigure Silage DescriptionFigure Other DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Agricultural Balers Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Agricultural Balers Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Agricultural BalersFigure Production Process of Agricultural BalersFigure Manufacturing Cost Structure of Agricultural BalersFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table Shen Yang Fang Ke ProfileTable Shen Yang Fang Ke Production, Value, Price, Gross Margin 2015-2020Table John Deere ProfileTable John Deere Production, Value, Price, Gross Margin 2015-2020Table Foton Lovol ProfileTable Foton Lovol Production, Value, Price, Gross Margin 2015-2020Table An Yang Yu Gong ProfileTable An Yang Yu Gong Production, Value, Price, Gross Margin 2015-2020Table New Holland ProfileTable New Holland Production, Value, Price, Gross Margin 2015-2020Table Abbriata ProfileTable Abbriata Production, Value, Price, Gross Margin 2015-2020Table Claas ProfileTable Claas Production, Value, Price, Gross Margin 2015-2020Table Yulong Machinery ProfileTable Yulong Machinery Production, Value, Price, Gross Margin 2015-2020Table Kuhn ProfileTable Kuhn Production, Value, Price, Gross Margin 2015-2020Table Krone ProfileTable Krone Production, Value, Price, Gross Margin 2015-2020Table Case IH ProfileTable Case IH Production, Value, Price, Gross Margin 2015-2020Table Shanghai Star ProfileTable Shanghai Star Production, Value, Price, Gross Margin 2015-2020Table Vermeer ProfileTable Vermeer Production, Value, Price, Gross Margin 2015-2020Table Massey Ferguson ProfileTable Massey Ferguson Production, Value, Price, Gross Margin 2015-2020Table Minos ProfileTable Minos Production, Value, Price, Gross Margin 2015-2020Figure Global Agricultural Balers Sales and Growth Rate (2015-2020)Figure Global Agricultural Balers Revenue ($) and Growth (2015-2020)Table Global Agricultural Balers Sales by Regions (2015-2020)Table Global Agricultural Balers Sales Market Share by Regions (2015-2020)Table Global Agricultural Balers Revenue ($) by Regions (2015-2020)Table Global Agricultural Balers Revenue Market Share by Regions (2015-2020)Table Global Agricultural Balers Revenue Market Share by Regions in 2015Table Global Agricultural Balers Revenue Market Share by Regions in 2019Figure North America Agricultural Balers Sales and Growth Rate (2015-2020)Figure Europe Agricultural Balers Sales and Growth Rate (2015-2020)Figure Asia-Pacific Agricultural Balers Sales and Growth Rate (2015-2020)Figure Middle East and Africa Agricultural Balers Sales and Growth Rate (2015-2020)Figure South America Agricultural Balers Sales and Growth Rate (2015-2020)Figure North America Agricultural Balers Revenue ($) and Growth (2015-2020)Table North America Agricultural Balers Sales by Countries (2015-2020)Table North America Agricultural Balers Sales Market Share by Countries (2015-2020)Figure North America Agricultural Balers Sales Market Share by Countries in 2015Figure North America Agricultural Balers Sales Market Share by Countries in 2019Table North America Agricultural Balers Revenue ($) by Countries (2015-2020)Table North America Agricultural Balers Revenue Market Share by Countries (2015-2020)Figure North America Agricultural Balers Revenue Market Share by Countries in 2015Figure North America Agricultural Balers Revenue Market Share by Countries in 2019Figure United States Agricultural Balers Sales and Growth Rate (2015-2020)Figure Canada Agricultural Balers Sales and Growth Rate (2015-2020)Figure Mexico Agricultural Balers Sales and Growth (2015-2020)Figure Europe Agricultural Balers Revenue ($) Growth (2015-2020)Table Europe Agricultural Balers Sales by Countries (2015-2020)Table Europe Agricultural Balers Sales Market Share by Countries (2015-2020)Figure Europe Agricultural Balers Sales Market Share by Countries in 2015Figure Europe Agricultural Balers Sales Market Share by Countries in 2019Table Europe Agricultural Balers Revenue ($) by Countries (2015-2020)Table Europe Agricultural Balers Revenue Market Share by Countries (2015-2020)Figure Europe Agricultural Balers Revenue Market Share by Countries in 2015Figure Europe Agricultural Balers Revenue Market Share by Countries in 2019Figure Germany Agricultural Balers Sales and Growth Rate (2015-2020)Figure UK Agricultural Balers Sales and Growth Rate (2015-2020)Figure France Agricultural Balers Sales and Growth Rate (2015-2020)Figure Italy Agricultural Balers Sales and Growth Rate (2015-2020)Figure Spain Agricultural Balers Sales and Growth Rate (2015-2020)Figure Russia Agricultural Balers Sales and Growth Rate (2015-2020)Figure Asia-Pacific Agricultural Balers Revenue ($) and Growth (2015-2020)Table Asia-Pacific Agricultural Balers Sales by Countries (2015-2020)Table Asia-Pacific Agricultural Balers Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Agricultural Balers Sales Market Share by Countries in 2015Figure Asia-Pacific Agricultural Balers Sales Market Share by Countries in 2019Table Asia-Pacific Agricultural Balers Revenue ($) by Countries (2015-2020)Table Asia-Pacific Agricultural Balers Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Agricultural Balers Revenue Market Share by Countries in 2015Figure Asia-Pacific Agricultural Balers Revenue Market Share by Countries in 2019Figure China Agricultural Balers Sales and Growth Rate (2015-2020)Figure Japan Agricultural Balers Sales and Growth Rate (2015-2020)Figure South Korea Agricultural Balers Sales and Growth Rate (2015-2020)Figure Australia Agricultural Balers Sales and Growth Rate (2015-2020)Figure India Agricultural Balers Sales and Growth Rate (2015-2020)Figure Southeast Asia Agricultural Balers Sales and Growth Rate (2015-2020)Figure Middle East and Africa Agricultural Balers Revenue ($) and Growth (2015-2020) continued

About HongChun Research:HongChun Research main aim is to assist our clients in order to give a detailed perspective on the current market trends and build long-lasting connections with our clientele. Our studies are designed to provide solid quantitative facts combined with strategic industrial insights that are acquired from proprietary sources and an in-house model.

Contact Details:Jennifer GrayManager Global Sales+ 852 8170 0792[emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

See original here:
Jennifer.grey The Daily Chronicle - The Daily Chronicle

Read More...

Page 444«..1020..443444445446..450460..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick